WO1997033176A1 - Graphitic nanotubes in luminescence assays - Google Patents
Graphitic nanotubes in luminescence assays Download PDFInfo
- Publication number
- WO1997033176A1 WO1997033176A1 PCT/US1997/003653 US9703653W WO9733176A1 WO 1997033176 A1 WO1997033176 A1 WO 1997033176A1 US 9703653 W US9703653 W US 9703653W WO 9733176 A1 WO9733176 A1 WO 9733176A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- fibrils
- assay
- analyte
- substance
- interest
- Prior art date
Links
- 0 C*(C)NC(CN)=* Chemical compound C*(C)NC(CN)=* 0.000 description 3
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F9/00—Artificial filaments or the like of other substances; Manufacture thereof; Apparatus specially adapted for the manufacture of carbon filaments
- D01F9/08—Artificial filaments or the like of other substances; Manufacture thereof; Apparatus specially adapted for the manufacture of carbon filaments of inorganic material
- D01F9/12—Carbon filaments; Apparatus specially adapted for the manufacture thereof
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y40/00—Manufacture or treatment of nanostructures
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B32/00—Carbon; Compounds thereof
- C01B32/15—Nano-sized carbon materials
- C01B32/158—Carbon nanotubes
- C01B32/168—After-treatment
- C01B32/174—Derivatisation; Solubilisation; Dispersion in solvents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
- C07K17/02—Peptides being immobilised on, or in, an organic carrier
- C07K17/06—Peptides being immobilised on, or in, an organic carrier attached to the carrier via a bridging agent
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F11/00—Chemical after-treatment of artificial filaments or the like during manufacture
- D01F11/10—Chemical after-treatment of artificial filaments or the like during manufacture of carbon
- D01F11/14—Chemical after-treatment of artificial filaments or the like during manufacture of carbon with organic compounds, e.g. macromolecular compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
- G01N33/5438—Electrodes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
- G01N33/553—Metal or metal coated
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01M—PROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY
- H01M4/00—Electrodes
- H01M4/02—Electrodes composed of, or comprising, active material
- H01M4/36—Selection of substances as active materials, active masses, active liquids
- H01M4/60—Selection of substances as active materials, active masses, active liquids of organic compounds
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B2202/00—Structure or properties of carbon nanotubes
- C01B2202/20—Nanotubes characterized by their properties
- C01B2202/34—Length
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B2202/00—Structure or properties of carbon nanotubes
- C01B2202/20—Nanotubes characterized by their properties
- C01B2202/36—Diameter
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
- G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
- G01N2030/8859—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample inorganic compounds
- G01N2030/8863—Fullerenes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/66—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light electrically excited, e.g. electroluminescence
- G01N21/69—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light electrically excited, e.g. electroluminescence specially adapted for fluids, e.g. molten metal
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/76—Chemiluminescence; Bioluminescence
-
- G—PHYSICS
- G11—INFORMATION STORAGE
- G11C—STATIC STORES
- G11C13/00—Digital stores characterised by the use of storage elements not covered by groups G11C11/00, G11C23/00, or G11C25/00
- G11C13/02—Digital stores characterised by the use of storage elements not covered by groups G11C11/00, G11C23/00, or G11C25/00 using elements whose operation depends upon chemical change
- G11C13/025—Digital stores characterised by the use of storage elements not covered by groups G11C11/00, G11C23/00, or G11C25/00 using elements whose operation depends upon chemical change using fullerenes, e.g. C60, or nanotubes, e.g. carbon or silicon nanotubes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E60/00—Enabling technologies; Technologies with a potential or indirect contribution to GHG emissions mitigation
- Y02E60/10—Energy storage using batteries
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/968—High energy substrates, e.g. fluorescent, chemiluminescent, radioactive
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/805—Optical property
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/806—Electrical property or magnetic property
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/70—Nanostructure
- Y10S977/734—Fullerenes, i.e. graphene-based structures, such as nanohorns, nanococoons, nanoscrolls or fullerene-like structures, e.g. WS2 or MoS2 chalcogenide nanotubes, planar C3N4, etc.
- Y10S977/735—Carbon buckyball
- Y10S977/737—Carbon buckyball having a modified surface
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/70—Nanostructure
- Y10S977/734—Fullerenes, i.e. graphene-based structures, such as nanohorns, nanococoons, nanoscrolls or fullerene-like structures, e.g. WS2 or MoS2 chalcogenide nanotubes, planar C3N4, etc.
- Y10S977/742—Carbon nanotubes, CNTs
Definitions
- This application relates generally to methods and apparatus for conducting binding assays, more particularly to those which measure the presence of an analyte of interest by measuring luminescence emitted by one or more labeled components of the assay system. More specifically, the invention relates to precise, reproducible, accurate homogeneous or heterogeneous specific binding assays of improved sensitivity in which the luminescent component is concentrated in the assay composition and collected on the detection system before being caused to electrochemiluminescence.
- a very substantial body of art has been developed based upon the well known binding reactions, e.g., antigen-antibody reactions, nucleic acid hybridization techniques, and protein-ligand systems.
- binding reactions e.g., antigen-antibody reactions, nucleic acid hybridization techniques, and protein-ligand systems.
- the high degree of specificity in many biochemical and biological binding systems has led to many assay methods and systems of value in research and diagnostics.
- an analyte of interest is indicated by the presence or absence of an observable ••label" attached to one or more of the binding materials.
- labels which can be made to luminesce through photochemical, chemical, and electrochemical means.
- Photoluroinescence is the process whereby a material is induced to luminesce when it absorbs electromagnetic radiation. Fluorescence and phosphorescence are types of photoluminescence.
- Cyhe iluminescent H processes entail the creation of luminescent species by chemical transfer of energy.
- Electrohemiluminescence entails creation of luminescent species electrochemically.
- Chemiluminescent assay techniques where a sample containing an analyte of interest is mixed with a reactant labeled with a chemiluminescent label have been developed. The reactive mixture is incubated and some portion of the labeled reactant binds to the analyte. After incubation, the bound and unbound fractions of the mixture are separated and the concentration of the label in either or both fractions can be determined by chemiluminescent techniques. The level of chemiluminescence determined in one or both fractions indicates the amount of analyte of interest in the biological sample.
- Electrochemiluminescent (ECL) assay techniques are an improvement on chemiluminescent techniques. They provide a sensitive and precise measurement of the presence and concentration of an analyte of interest. In such techniques, the incubated sample is exposed to a voltammetric working electrode in order to trigger lumin ⁇ escence. In the proper chemical environment, such electrochemiluminescence is triggered by a voltage impressed on the working electrode at a particular time and in a particular manner. The light produced by the label is measured and indicates the presence or quantity of the analyte.
- U.S. 89/04919 relates to a composition for an assay based upon a binding reaction for the measurement of luminescent phenomenon, which composition includes a plurality of suspended particles having a surface capable of binding to a component of the assay mixture.
- it is directed to a system for detecting or quantitating an analyte of interest in a sample, which system is capable of conducting the assay methods using the assay compositions of the inventions.
- the system includes means for inducing the label compound in the assay medium to luminesce, and means for measuring the luminescence to detect the presence of the analyte of interest in the sample.
- U.S. 89/04919 is directed to methods for the detection of an analyte of interest in a sample, which method includes the steps of (1) forming a composition comprising (a) a sample suspected of containing an analyte of interest, (b) an assay- performance-substance selected from the group consisting of (i) analyte of interest or analog of the analyte of interest, (ii) a binding partner of the analyte of interest or its said analog, and (iii) a reactive component capable of binding with (i) or (ii) , wherein one of said substances is linked to a label compound having a chemical moiety capable of being induced to luminesce, and (c) a plurality of suspended particles capable of specifically binding with the analyte and/or a substance defined in (b) (i) , (ii), or (iii); (2) incubating the composition to form a complex which includes a particle and said label compound; (3) inducing the label
- Analogs of the analyte of interest which may be natural or synthetic, are compounds which have binding properties comparable to the analyte, but include compounds of higher or lower binding capability as well. Binding partners suitable for use in the present invention are well-known. Examples are antibodies, enzymes, nucleic acids, lectins, cofactors and receptors.
- the reactive components capable of binding with the analyte or its analog and/or with a binding partner thereof may be a second antibody or a protein such as Protein A or Protein G or may be avidin or biotin or another component known in the art to enter into binding reactions.
- the luminescence arises from electrochemiluminescence (ECL) induced by exposing the label compound, whether bound or unbound to specific binding partners, to a voltammetric working electrode.
- ECL electrochemiluminescence
- the ECL reactive mixture is controllably triggered to emit light by a voltage impressed on the working electrode at a particular time and in a particular manner to generate light.
- the emission of visible light is an advantageous feature the composition or system may emit other types of electromagnetic radiation, such as infrared or ultraviolet light, X-rays, microwaves, etc.
- electrohemiluminescence “luminescence,” “luminescent,” and “luminesce” includes the emission of light and other forms of electromagnetic radiation.
- the probability of the tunneling phenomenon occurring between two species is fairly high if the distance is less than 25 Angstroms (2.5 n ) but is fairly low if the distance is greater.
- the distance of 25 A is a rule-of-thumb used by those skilled in the art but is not an absolute limitation.
- Carbon fibrils are vermicular carbon deposits having diameters less than l.O ⁇ , preferably less than 0.5 ⁇ , and even more preferably less than 0.2 ⁇ . They exist in a variety of forms and have been prepared through the catalytic decomposition of various carbon-containing gases at metal surfaces. Such vermicular carbon deposits have been observed almost since the advent of electron microscopy. A good early survey and reference is found in Baker and Harris, Chemistry and Physics of Carbon. Walker and Thrower ed. , Vol. 14, 1978, p. 83, hereby incorporated by reference. See also, Rodriguez, N. , J.
- Tennent U.S. Patent No. 4,663,230, hereby incorporated by reference, succeeded in growing cylindrical ordered graphite cores, uncontaminated with pyrolytic carbon.
- the Tennent invention provided access to smaller diameter fibrils, typically 35 to 700 A (0.0035 to 0.070 ⁇ ) and to an ordered, "as grown" graphitic surface. Fibrillar carbons of less perfect structure, but also without a pyrolytic carbon outer layer have also been grown.
- Fibrils, buckytubes and nanofibers are distinguishable from continuous carbon fibers commercially available as reinforcement materials.
- continuous carbon fibers In contrast to fibrils, which have, desirably large, but unavoidably finite aspect ratios, continuous carbon fibers have aspect ratios (L/D) of at least IO 4 and often IO 6 or more.
- L/D aspect ratios
- the diameter of continuous fibers is also far larger than that of fibrils, being always >1.0 ⁇ and typically 5 to 7 ⁇ .
- Continuous carbon fibers are made by the pyrolysis of organic precursor fibers, usually rayon, polyacrylonitrile (PAN) and pitch. Thus, they may include heteroatoms within their structure.
- organic precursor fibers usually rayon, polyacrylonitrile (PAN) and pitch.
- PAN polyacrylonitrile
- They may include heteroatoms within their structure.
- the graphitic nature of "as made" continuous carbon fibers varies, but they may be subjected to a subsequent graphitization step. Differences in degree of graphitization, orientation and crystallinity of graphite planes, if they are present, the potential presence of heteroatoms and even the absolute difference in substrate diameter make experience with continuous fibers poor predictors of nanofiber chemistry.
- U.S. Patent No. 4,663,230 describes carbon fibrils that are free of a continuous thermal carbon overcoat and have multiple graphitic outer layers that are substantially parallel to the fibril axis. As such they may be characterized as having their c-axes, the axes which are perpendicular to the tangents of the curved layers of graphite, substantially perpendicular to their cylindrical axes. They generally have diameters no greater than O.l ⁇ and length to diameter ratios of at least 5. Desirably they are substantially free of a continuous thermal carbon overcoat, i.e., pyrolytically deposited carbon resulting from thermal cracking of the gas feed used to prepare them.
- Carbon nanotubes of a morphology similar to the catalytically grown fibrils described above have been grown in a high temperature carbon arc (Iijima, Nature 354 56 1991) . It is now generally accepted (Weaver, Science 265 1994) that these arc-grown nanofibers have the same morphology as the earlier catalytically grown fibrils of Tennent. Arc grown carbon nanofibers are also useful in the invention.
- Objects of the Invention It is therefore an object of this invention to provide luminescence assays using particles having a high surface area for immobilization of assay performance substances to achieve advantageously high light emission. It is also an object of this invention to provide compositions and assays using graphitic nanotubes (fibrils) which can be labeled with compounds capable of being induced to luminesce. It is further object to provide functionalized fibrils for use in such assays.
- ECL moiety "metal-containing ECL moiety” "label,” “label compound,” and “label substance,” are used interchangeably. It is within the scope of the invention for the species termed “ECL moiety,” “metal- containing ECL moiety,” “organo-metallic,” “metal chelate,” “transition metal chelate” “rare earth metal chelate,” “label compound,” “label substance” and “label” to be linked to molecules such as an analyte or an analog thereof, a binding partner of the analyte or an analog thereof, and further binding partners of such aforementioned binding partner, or a reactive component capable of binding with the analyte, an analog thereof or a binding partner as mentioned above.
- the above- mentioned species can also be linked to a combination of one or more binding partners and/or one or more reactive components. Additionally, the aforementioned species can also be linked to an analyte or its analog bound to a binding partner, a reactive component, or a combination of one or more binding partners and/or one or more reactive components. It is also within the scope of the invention for a plurality of the aforementioned species to be bound directly, or through other molecules as discussed above, to an analyte or its analog. For purposes of brevity, these ligands are referred to as an assay-performance-substance.
- collection and concentration of complex may be used interchangeably to describe the concentration of complex within the assay composition and the collection of complex at, e.g., an electrode surface.
- Fig. 1 is a schematic drawing of a cell for performing the microparticulate-based nonseparation and separation assays of the invention.
- Fig. 2 is a simplified diagram of a voltage control apparatus for use with the cell of Fig. 1.
- Fig. 3 is a schematic representation showing the specific enzyme hydrolysis sites on Ru(bpy) 3 2+ -labeled peptide fibrils.
- Fig. 4 is a schematic representation of a DNA probe assay using avidin-fibrils.
- Fig. 5 is a schematic representation of a reaction scheme for the preparation of bifunctional fibrils by the addition of N e -(tert-butoxycarbonyl)-L- lysine.
- Fig. 6 is a schematic representation of a reaction scheme for synthesizing the ECL-based, bifunctional biosensor fibril.
- Fig. 7 is a schematic representation of bifunctional ECL-based biosensor fibril.
- Fig. 8 is a schematic representation of the reaction catalyzed by D-glucose-6-phosphate dehydrogenase.
- Fig. 9 is a graph showing the ECL detection of glucose-6-phosphate dehydrogenase using a fibril- supported ECL-based biosensor.
- Fig. 10 is a schematic representation of an alcohol dehydrogenase (ADH) based ECL biosensor.
- Fig. 11 is a schematic representation of an ADH-based biosensor immobilized on Dynal M450 beads (left) and immobilized on alkyl fibrils (right) .
- Fig. 12 is a graph showing ECL detection of ethanol using an enzyme biosensor immobilized on beads and fibrils.
- Fig. 13 is a graphical representation of an assay of Ru(bpy) 3 2+ binding to carboxy fibrils and PEG- odified fibrils prepared by two different methods. Brief Description of the Invention
- the invention is in a nanotube to which is attached a component linked to a label compound capable of being induced to luminesce.
- said nanotube is a graphitic nanotube and said luminescence is electrochemiluminescence.
- said component is an enzyme biosensor.
- the invention is also in a composition for the detection of an analyte of interest present in a sample, which composition comprises: (i) a graphitic nanotube having a functional group and (ii) an assay-performance-substance linked to said functional group, said assay-performance-substance being capable of binding, directly or indirectly, to the analyte.
- the assay-performance- substance being bound to said functional group is in turn bound to the analyte.
- the composition further comprises a second assay-performance-substance bound to the analyte, said second assay-performance-substance being linked to a label compound capable of being induced to luminesce.
- the assay-performance-substance contains at least one substance selected from the group consisting of (i) added analyte of interest or added analogue of said analyte;
- the particles are functionalized fibrils, i.e., fibrils whose surface has been reacted or contacted with one or more substances to provide active sites thereon for chemical substitution or physical adsorption of different chemical species.
- Fibrils have also been oxidized non-uniformly by treatment with nitric acid.
- International Application PCT/US94/10168 discloses the formation of oxidized fibrils containing a mixture of functional groups.
- Hoogenvaad, M.S., et al. Metal Catalysts supported on a Novel Carbon Support", Presented at Sixth International Conference on Scientific Basis for the Preparation of Heterogeneous Catalysts, Brussels, Belgium, September 1994
- Such pretreatment with acid is a standard step in the preparation of carbon- supported noble metal catalysts, where, given the usual sources of such carbon, it serves as much to clean the surface of undesirable materials as to functionalize it.
- the particles are preferably functionalized fibrils which broadly have the formula
- n is an integer
- L is a number less than O.ln
- m is a number less than 0.5n
- each of R is the same and is selected from S0 3 H, COOH, NH 2 , OH, CHO, CN, C0C1, halide, COSH, SH, COOR', SR', SiR , 3 , Si-fOR'-)- y R' 3 _ y , Si-fO-SiR' 2 -K>R' , R" , L A1R' 2 , Hg-X, T1Z 2 and Mg-X, y is an integer equal to or less than 3, R' is alkyl, aryl, cycloalkyl or aralkyl,
- R" is fluoroalkyl, fluoroaryl, fluorocycloalkyl, fluoroaralkyl or cycloaryl,
- X is halide
- Z is carboxylate or trifluoroacetate.
- the carbon atoms, C n are surface carbons of a substantially cylindrical, graphitic nanotube of substantially constant diameter.
- the nanotubes include those having a length to diameter ratio of greater than 5 and a diameter of less than 0.5 ⁇ , preferably less than O.l ⁇ .
- the nanotubes can also be substantially cylindrical, graphitic nanotubes which are substantially free of pyrolytically deposited carbon, more preferably those characterized by having a projection of the graphite layers on the fibril axis which extends for a distance of at least two fibril diameters and/or those having cylindrical graphitic sheets whose c-axes are substantially perpendicular to their cylindrical axis. These compositions are uniform in that each of R is the same.
- the particles also include non-uniformly substituted nanotubes. These include compositions of the formula
- Functionalized nanotubes having the formula [CnH L -r Rm where n, L, m, R and R' have the same meaning as above and the carbon atoms are surface carbon atoms of a fishbone fibril having a length to diameter ratio greater than 5, are also included as particles within the invention. These may be uniformly or non-uniformly substituted. Preferably, the nanotubes are free of thermal overcoat and have diameters less than 0.5 ⁇ . Also included as particles in the invention are functionalized nanotubes having the formula [CnH L -r Rm where n, L, m, R and R' have the same meaning as above and the carbon atoms are surface carbon atoms of a fishbone fibril having a length to diameter ratio greater than 5, are also included as particles within the invention. These may be uniformly or non-uniformly substituted. Preferably, the nanotubes are free of thermal overcoat and have diameters less than 0.5 ⁇ . Also included as particles in the invention are functionalized nanotubes having the formula
- C n are surface carbons of a substantially cylindrical, graphitic nanotube of substantially constant diameter.
- the nanotubes have a length to diameter ratio of greater than 5 and a diameter of less than 0.5 ⁇ , preferably less than O.l ⁇ .
- the nanotubes may be nanotubes which are substantially free of pyrolytically deposited carbon.
- the nanotubes are those in which the projection of the graphite layers on the fibril axes extends for a distance of at least two fibril diameters and/or those having cylindrical graphitic sheets whose c-axes are substantially perpendicular to their cylindrical axis.
- edge or basal plane carbons of lower, interior layers of the nanotube may be exposed.
- surface carbon includes all the carbons, basal plane and edge, of the outermost layer of the nanotube, as well as carbons, both basal plane and/or edge, of lower layers that may be exposed at defect sites of the outermost layer.
- the edge carbons are reactive and must contain some heteroatom or group to satisfy carbon valency.
- the substituted nanotubes described above may advantageously be further functionalized.
- Such compositions include compositions of the formula
- Y is an appropriate functional group of a protein, a peptide, an enzyme, an antibody, a nudeotide, an oligonucleotide, an antigen, or an enzyme substrate, enzyme inhibitor or the transition state analog of an enzyme substrate or is selected from R , -OH, R'-NH 2 , R'SH, R'CHO, R'CN, R'X, R'SiR' 3 , R'Si-fOR'-)- y R' 3 _ y , R'Si-fO- SiR' 2 0R', R'-R", R'-N-CO, (C ⁇ OT- ⁇ , - CaHgC- ⁇ H, -C 2 H 4 0) w - R', (C 3 H 6 0) w -R' and R''-N-CO, (C ⁇ OT- ⁇ , - CaHgC- ⁇ H, -C 2 H 4 0) w - R', (C 3 H 6 0)
- the carbon atoms, C n are surface carbons of a substantially cylindrical, graphitic nanotube of substantially constant diameter.
- the nanotubes include those having a length to diameter ratio of greater than 5 and a diameter of less than O.l ⁇ , preferably less than 0.05 ⁇ .
- the nanotubes can also be substantially cylindrical, graphitic nanotubes which are substantially free of pyrolytically deposited carbon. More preferably they are characterized by having a projection of the graphite layers on the fibril axes which extends for a distance of at least two fibril diameters and/or they are comprised of cylindrical graphitic sheets whose c-axes are substantially perpendicular to their cylindrical axes.
- the nanotubes are free of thermal overcoat and have diameters less than 0.5 ⁇ .
- C n are surface carbons of a substantially cylindrical, graphitic nanotube of substantially constant diameter.
- the nanotubes include those having a length to diameter ratio of greater than 5 and a diameter of less than 0.5 ⁇ , preferably less than O.l ⁇ .
- the nanotubes can also be substantially cylindrical, graphitic nanotubes which are substantially free of pyrolytically deposited carbon.
- the nanotubes are free of thermal overcoat and have diameters less than 0.5 ⁇ .
- the particles of the invention also include nanotubes upon which certain cyclic compounds are adsorbed. These include compositions of matter of the formula
- C n H L ⁇ [X-R a ] m where n is an integer, L is a number less than O.ln, m is less than 0.5n, a is zero or a number less than 10, X is a polynuclear aromatic, polyheteronuclear aromatic or metallopolyheteronuclear aromatic moiety and R is as recited above.
- the carbon atoms, C n are surface carbons of a substantially cylindrical, graphitic nanotube of substantially constant diameter.
- the nanotubes include those having a length to diameter ratio of greater than 5 and a diameter of less than 0.5 ⁇ , preferably less than O.l ⁇ .
- the nanotubes can also be substantially cylindrical, graphitic nanotubes which are substantially free of pyrolytically deposited carbon and more preferably those characterized by having a projection of the graphite layers on said fibril axes which extend for a distance of at least two fibril diameters and/or those having cylindrical graphitic sheets whose c-axes are substantially perpendicular to their cylindrical axes.
- the nanotubes are free of thermal overcoat and have diameters less than 0.5 ⁇ .
- Preferred cyclic compounds are planar macrocycles as described on p. 76 of Cotton and Wilkinson, Advanced Organic Chemistry. More preferred cyclic compounds for adsorption are porphyrins and phthalocyanines.
- compositions include compounds of the formula
- the carbon fibrils functionalized as described above may be incorporated in a matrix.
- the matrix is an organic polymer (e.g., a thermoset resin such as epoxy, bismaleimide, polyamide, or polyester resin; a thermoplastic resin; a reaction injection molded resin; or an elastomer such as natural rubber, styrene- butadiene rubber, or cis-l,4-polybutadiene) ; an inorganic polymer (e.g., a polymeric inorganic oxide such as glass), a metal (e.g., lead or copper), or a ceramic material (e.g., Portland cement).
- a thermoset resin such as epoxy, bismaleimide, polyamide, or polyester resin
- a thermoplastic resin such as epoxy, bismaleimide, polyamide, or polyester resin
- a reaction injection molded resin such as natural rubber, styrene- butadiene rubber, or cis-l,4-polybutadiene
- the functionalized fibrils are better dispersed into polymer systems because the modified surface properties are more compatible with the polymer, or, because the modified functional groups (particularly hydroxyl or amine groups) are bonded directly to the polymer as terminal groups.
- polymer systems such as polycarbonates, polyurethanes, polyesters or polyamides/imides bond directly to the fibrils making the fibrils easier to disperse with improved adherence.
- Functional groups are introduced onto the surface of carbon fibrils by contacting carbon fibrils with a strong oxidizing agent for a period of time sufficient to oxidize the surface of said fibrils and further contacting said fibrils with a reactant suitable for adding a functional group to the oxidized surface.
- the oxidizing agent is comprised of a solution of an alkali metal chlorate in a strong acid.
- the alkali metal chlorate is sodium chlorate or potassium chlorate.
- the strong acid used is sulfuric acid. Periods of time sufficient for oxidation are from about 0.5 hours to about 24 hours.
- a network of carbon fibrils are produced by contacting carbon fibrils with an oxidizing agent for a period of time sufficient to oxidize the surface of the carbon fibrils, contacting the surface-oxidized carbon fibrils with reactant suitable for adding a functional group to the surface of the carbon fibrils, and further contacting the surface-functionalized fibrils with a cross-linking agent effective for producing a network of carbon fibrils.
- a preferred cross-linking agent is a polyol, polyamine or polycarboxylic acid.
- the functionalized fibrils may also be in the form of rigid networks of fibrils.
- a well-dispersed, three-dimensional network of acid-functionalized fibrils may, for example, be stabilized by cross-linking the acid groups (inter-fibril) with polyols or polyamines to form a rigid network.
- the fibril particles also include three- dimensional networks formed by linking functionalized fibrils of the invention. These complexes include at least two functionalized fibrils linked by one or more linkers comprising a direct bond or chemical moiety. These networks comprise porous media of remarkably uniform equivalent pore size. Although the interstices between these fibrils are irregular in both size and shape, they can be thought of as pores and characterized by the methods used to characterize porous media. The size of the interstices in such networks can be controlled by the concentration and level of dispersion of fibrils, and the concentration and chain lengths of the cross-linking agents.
- the complex including the particles may be collected on, e.g., an electrode surface where it is excited and induced to electrochemiluminescence by impressing a voltage on the electrode. While the invention is preferably carried out by collecting the complex in a measurement zone, i.e., on a surface at which it can be caused to luminesce, the invention also embraces methods wherein the complex is collected in a measurement zone and thereafter means are brought to that zone or other steps taken to induce and measure luminescence.
- the collection of the complex may be carried out by several different methods, including gravity settling, filtration, centrifugation and magnetic attraction of magnetically responsive particles which form part of the complex.
- the several embodiments are described in further detail below.
- the invention is also in a method for performing a binding assay for an analyte of interest present in a sample comprising the steps of: (a) forming a composition containing (i) said sample (ii) an assay-performance-substance which contains a component linked to a label compound capable of being induced to luminesce, and (iii) a plurality of functionalized graphitic nanotubes bound to an assay- performance-substance; (b) incubating said composition to form a complex which includes said functionalized graphitic nanotube and said label compound;
- said complex is collected on the surface of means for inducing luminescence and measuring said luminescence.
- the method is advantageously based upon measurement of electrochemiluminescence wherein said complex is collected at an electrode surface.
- the invention is also in a method for performing a binding assay for an analyte of interest present in a sample based upon measurement of electrochemiluminescence at an electrode surface comprising the steps: (a) forming a composition containing (i) said sample (ii) an assay-performance-substance which contains a component linked to a label compound capable of being induced to electrochemiluminesce, and
- the invention is further in a method for performing a binding assay for an analyte of interest present in a sample based upon measurement of electrochemiluminescence at an electrode surface comprising the steps:
- an assay-performance-substance which contains a component linked to a label compound capable of being induced to electrochemiluminesce, and ( ⁇ i) a plurality of magnetically responsive, suspended, functionalized, graphitic nanotubes bound to an assay-performance- substance;
- the invention is in a composition of matter for use as a reagent in a microparticulate- based binding assay comprising functionalized graphitic nanotubes and at least one other component selected from the group consisting of: 25
- an electrochemiluminescent-reaction enhancer provided; however, that no two components contained within any reagent composition are reactive with one another during storage so as to impair their function in the intended assay.
- the reagent may contain magnetically responsive graphitic nanotubes.
- the invention is also in an assay reagent for an assay based upon a binding reaction and the measurement of an electrochemiluminescent phenomenon comprising:
- the invention is further in a method for performing an assay for an analyte of interest present in a sample comprising the steps of:
- While batch assays can be performed, continuous or semi-continuous assays can be performed in flow cells.
- the solid-phase remains in the measurement cell while the solution flows through and exits the cell. If the solid-phase (e.g., particles) are more dense than water, i.e., have a density greater than that of water, (more than 1.0 g/mL) the force of gravity upon the particles causes them to fall to the bottom of the cell.
- the cell can be constructed such that the particles settle to the bottom as the fluid flows through the cell or the cell can be constructed such that the majority of the sample is contained in the cell in a columnar compartment above the working electrode of an ECL system. Sufficient dwell time in the cell must be provided to permit the particles to settle on the surface of the electrode before inducing ECL.
- the assay composition containing suspended fibrils having a density greater than the balance of the assay composition may be subjected to centrifugation in order to remove the particles to a measurement zone where they are subsequently brought into contact with, e.g. , an electrode to induce electrochemiluminescence or brought directly into contact with an electrode in the centrifugation step.
- the measurement cell is provided with means to rapidly rotate the sample and sample enclosure. Centrifugal force causes the fibrils in the sample to move outward from the axis of rotation of the sample enclosure and to collect on the outer surface of the sample enclosure.
- the outer surfaces of such sample enclosure may constitute the working electrode of an ECL measurement system.
- the fibrils may be removed by filtration from the assay composition.
- the particles need not have a density greater than the balance of the assay composition.
- the fibrils are separated from the solution and concentrated by drawing the solution through a filter, e.g. pumping and collecting the particles on the surface of the filter.
- This surface of the filter is, for example, coated with a thin metal film which can serve as the working electrode in an ECL detection system.
- the suspended fibrils are magnetically responsive, e.g. they may be paramagnetic or ferromagnetic, and are collected in a measurement zone or, preferably, directly at the surface of an electrode, by imposition of a magnetic field on the particles.
- the measurement cell is equipped with a magnet.
- the magnetic field of the magnet applies a force on the particles as they reside in a batch cell or as they flow through a flow cell, causing them to separate from the bulk of the solution onto the surface of the cell which is in closest proximity to the magnet. If the magnet is placed in a proper orientation and in close proximity to the working electrode of an ECL detection system the particles will concentrate on the surface of the working electrode.
- heterogeneous and homogeneous formats for binding assays can be implemented using the methods described above to collect and concentrate the complex on the surface of an electrode.
- a heterogeneous binding assay the complex is separated from the composition before measuring luminescence from the label.
- homogeneous assays no separation of the bound (to the solid phase) and unbound labeled reagents is made.
- the measured signal from the label is much greater than it would be in the absence of a collection step.
- the signal from the uncomplexed labeled reagents in contrast, is not changed.
- the signal from the collected complex is stronger than in an assay without collection of complex.
- the detection limit for the binding assay is, much improved as a result of the collection procedure.
- an in-situ separation step is included in the homogeneous binding assay procedure.
- a second fluid is pumped through the cell which is free of label or labeled reagents, thereby performing an in-situ wash or separation of the complex from unbound components of the assay composition.
- This assay procedure is technically a heterogeneous binding assay.
- the ability to perform the separation inside the measurement cell is advantageous in that it does not require additional separation apparatus and the procedure is generally much faster than external separation methods.
- Heterogeneous binding assays are conducted using the invention by mixing the components of the assay composition and allowing them to react for a predetermined length of time. The assay composition is then subjected to a separation step wherein the solution is separated from the particles.
- Electrochemiluminescence is then measured from either the complex or the solution. Measuring the ECL from the complex after a concentration step permits measurement of analyte with better accuracy and with a lower detection limit than is possible without concentration.
- the functionalized fibril is further reacted with avidin (an assay-performance-substance) to prepare it for use in an ECL assay.
- the so-modified fibril is then reacted with a biotinylated oligonucleotide (an assay-performance-substance) to form a fibril-avidin- biotin-oligonucleotide complex for use in a DNA probe assay.
- This complex can be used as a probe for an oligonucleotide analyte of interest which is complementary to said probe in a sandwich assay in the presence of a second oligonucleotide complementary to said analyte of interest labeled with an ECL moiety.
- the invention is broadly applicable to analytes of interest which are capable of entering into binding reactions. These reactions include, e.g. , antigen- antibody, ligand receptor, DNA and RNA interactions, and other known reactions.
- the invention relates to different methods and assays for qualitatively and quantitatively detecting the presence of such analytes of interest in a multicomponent sample.
- the Samples include, e.g. , antigen- antibody, ligand receptor, DNA and RNA interactions, and other known reactions.
- the invention relates to different methods and assays for qualitatively and quantitatively detecting the presence of such analytes of interest in a multicomponent sample.
- the sample which may contain the analyte of interest may be in solid, emulsion, suspension, liquid, or gas form, may be derived from, for example, cells and cell-derived products, water, food, blood, serum, hair, sweat, urine, feces, tissue, saliva, oils, organic solvents or air.
- the sample may further comprise, for example, water, acetonitrile, dimethyl sulfoxide, dimethyl formamide, n-methyl-pyrrolidone or alcohols or mixtures thereof.
- Typical analytes of interest are a whole cell or surface antigen, subcellular particle, virus, prion, viroid, antibody, antigen, hapten, fatty acid, nucleic acid, protein, lipoprotein, polysaccharide, lipopolysaccharide, glycoprotein, peptide, polypeptide, cellular metabolite, hormone, pharmacological agent, synthetic organic molecule, organometallic molecule, tranquilizer, barbiturate, alkaloid, steroid, vitamin, amino acid, sugar, lectin, recombinant or derived protein, biotin, avidin, streptavidin, or inorganic molecule present in the sample.
- the analyte of interest is present at a concentration of IO" 3 molar or less, for example, as low as IO" 12 molar or lower.
- the assay-performance-substance which is combined with the sample containing the analyte of interest contains at least one substance selected from the group consisting of (i) added analyte of interest or its analog, as defined above, (ii) a binding partner of the analyte of interest or its said analog, and (iii) a reactive component, as defined above, capable of binding with (i) or (ii) , wherein one of said substances is linked to a compound or moiety, e.g. an ECL moiety capable of being induced to luminesce.
- a compound or moiety e.g. an ECL moiety capable of being induced to luminesce.
- the labeled substance may be a whole cell or surface antigen, a subcellular particle, virus, prion, viroid, antibody, antigen, hapten, lipid, fatty acid, nucleic acid, polysaccharide, protein, lipoprotein, lipopolysaccharide, glycoprotein, peptide, polypeptide, cellular metabolite, hormone, pharmacological agent, tranquilizer, barbiturate, alkaloid, steroid, vitamin, amino acid, sugar, nonbiological polymer (preferably soluble) , lectin, recombinant or derived protein, synthetic organic molecule, organometallic molecule, inorganic molecule, biotin, avidin or streptavidin.
- the reagent is an electrochemiluminescent moiety conjugated to an antibody, antigen, nucleic acid, hapten, small nudeotide sequence, oligomer, ligand, enzyme, or biotin, avidin, streptavidin, Protein A, Protein G, or complexes thereof, or other secondary binding partner capable of binding to a primary binding partner through protein interactions.
- Analogs of the analyte of interest which can be natural or synthetic, are typically compounds which have binding properties comparable to the analyte, but can also be compounds of higher or lower binding capability.
- the reactive components capable of binding with the analyte or its analog, and/or with a binding partner thereof, and through which the ECL moiety can be linked to the analyte is suitably a second antibody or a protein such as Protein A or Protein G, or avidin or biotin or another component known in the art to enter into binding reactions.
- the ECL moieties are metal chelates.
- the metal of that chelate is suitably any metal such that the metal chelate will luminesce under the electrochemical conditions which are imposed on the reaction system in question.
- the metal of such metal chelates is, for instance, a transition metal (such as a d-block transition metal) or a rare earth metal.
- the metal is preferably ruthenium, osmium, rhenium, iridium, rhodium, platinum, indium, palladium, molybdenum, tech- netium, copper, chromium or tungsten. Especially preferred are ruthenium and osmium.
- the ligands which are linked to the metal in such chelates are usually heterocyclic or organic in nature, and play a role in determining whether or not the metal chelate is soluble in an aqueous environment or in an organic or other nonaqueous environment.
- the ligands can be polydentate, and can be substituted.
- Polydentate ligands include aromatic and aliphatic ligands.
- Suitable aromatic polydentate ligands include aromatic heterocyclic ligands.
- Preferred aromatic heterocyclic ligands are nitrogen-containing, such as, for example, bipyridyl, bipyrazyl, terpyridyl, and phenanthrolyl.
- Suitable substituents include for example, alkyl, substituted alkyl, aryl, substituted aryl, aralkyl, substituted aralkyl, carboxylate, carboxaldehyde, carboxamide, cyano, amino, hydroxy, imino, hydroxycarbonyl, aminocarbonyl, amidine, guanidinium, ureide, sulfur-containing groups, phosphorus containing groups, and the carboxylate ester of N-hydroxy- succinimide.
- the chelate may have one or more monodentate ligands, a wide variety of which are known to the art. Suitable monodentate ligands include, for example, carbon monoxide, cyanides, isocyanides, halides, and aliphatic, aromatic and heterocyclic phosphines, amines, stilbenes, and arsines.
- Suitable chelates are bis [(4,4'- carbomethoxy)-2,2'-bipyridine] 2-[3-(4-methyl-2,2'-bi- pyridine-4-yl)propyl]-l,3-dioxolane ruthenium (II); bis (2,2'bipyridine) [4-(butan-1-al)-4'-methyl-2,2'-bi- pyridine] ruthenium (II); bis (2,2'-bipyridine) [4-(4'- methyl-2,2'-bipyridine-4'-yl)-butyric acid] ruthenium (II); tris (2,2'bipyridine) ruthenium (II); (2,2'- bipyridine) [bis-bis(l,2-diphenylphosphino)ethylene] 2- [3-(4-methyl-2,2'-bipyridine-4'-yl)propyl]-1,3-dioxolane rut
- ECL moieties are described in commonly assigned PCT published application US87/00987 and PCT published application 88/0394.
- the function of the ECL moieties is to emit electromagnetic radiation as a result of introduction into the reaction system of electrochemical energy. In order to do this, they must be capable of being stimulated to an excited energy state and also capable of emitting electromagnetic radiation, such as a photon of light, upon descending from that excited state.
- electromagnetic radiation such as a photon of light
- the amount of metal chelate or other metal- containing ECL moiety incorporated in accordance with the invention will vary from system to system. Generally, the amount of such moiety utilized is that amount which is effective to result in the emission of a detectable, and if desired, quantitatable, emission of electromagnetic energy, from the aforementioned composition or system.
- the detection and/or quantitation of an analyte of interest is typically made from a comparison of the luminescence from a sample containing an analyte of interest and an ECL moiety to the luminescence emitted by a calibration standard developed with known amounts of the analyte of interest and ECL moiety. This assumes a homogeneous format. In the heterogeneous mode, a separation as discussed previously is carried out prior to ECL analysis.
- the identity and amount of the metal- containing ECL moiety will vary from one system to another, depending upon prevailing conditions.
- the appropriate metal-containing ECL moiety, and sufficient amount thereof to obtain the desired result can be determined empirically by those of ordinary skill in the art, once equipped with the teachings herein, without undue experimentation, gra hitic Nanptubes
- Nanotubes may be used as a solid support for analytical applications in various geometries including as dispersed, as aggregates, as mats or films, attached to larger supports including beads, or mixed with another material and used as a composite, for example in a porous column.
- Nanotubes primarily consist of chemically-modifiable graphitic carbon. They generally have diameters no greater than 0.1 ⁇ m and length to diameter ratios of at least 5. Typically, they have diameters of 0.01 ⁇ m and lengths of 1-10 ⁇ m.
- the fibrils are functionalized fibrils, i.e. fibrils whose surfaces are uniformly or non-uniformly modified so as to have a functional chemical moiety associated therewith.
- the fibril surfaces may be functionalized by reaction with oxidizing or other chemical media.
- the fibril surfaces may be uniformly modified either by chemical reaction or by physical adsorption of species which themselves have a chemical reactivity.
- the fibril surfaces may be modified e.g. by oxidation and may be further modified by reaction with other functional groups.
- the fibril surfaces may be modified with a spectrum of functional groups so that the fibrils can be chemically reacted or physically bonded to chemical groups in a variety of substrates including binding components in electrochemiluminescence assays.
- Complex structures of fibrils may be obtained by linking functional groups on the fibrils with one another by a range of linker chemistries.
- the functionalized fibrils may be reacted with various biomolecules to prepare them for use in ECL assays.
- Various assay-performance-substances e.g. antibodies, receptors, or other binding moieties, can be reacted with the functionalized fibrils to prepare them for use in ECL assays.
- the Particles Graphitic nanotubes may be covalently or noncovalently attached to larger solid phases, such as particles.
- the particles advantageously comprise micro ⁇ particulate matter having a diameter of 0.05 ⁇ m to 200 ⁇ m, preferably 0.1 ⁇ m to 100 ⁇ m, most preferably 0.5 ⁇ m to 10 ⁇ m, and a surface component capable of binding to the analyte and/or one or more of the other substances defined in subparagraphs (b) (i) , (b) (ii) , or (b) (iii) above.
- the microparticulate matter may be crossiinked starch, dextrans, cellulose, proteins, organic polymers, styrene copolymer such as styrene/butadiene copolymer, acrylonitrile/butadiene/ styrene copolymer, vinylacetyl acrylate copolymer, or vinyl chloride/acrylate copolymer, inert inorganic particles, chromium dioxide, oxides of iron, silica, silica mixtures, and proteinaceous matter, or mixtures thereof. Desirably, the particles are suspended in the ECL system. Assay Media
- the electrolyte is a phase through which charge is carried by ions.
- the electrolyte is in the liquid phase, and is a solution of one or more salts or other species in water, an organic liquid or mixture of organic liquids, or a mixture of water and one or more organic liquids.
- other forms of electrolyte are also useful in certain embodiments of the invention.
- the electrolyte may be a dispersion of one or more substances in a fluid —e.g., a liquid, a vapor, or a supercritical fluid —or may be a solution of one or more substances in a solid, a vapor or supercritical fluid.
- a fluid e.g., a liquid, a vapor, or a supercritical fluid
- the electrolyte is suitably a solution of a salt in water.
- the salt can be a sodium salt or a potassium salt preferably, but incorporation of other cations is also suitable in certain embodiments, as long as the cation does not interfere with the electrochemiluminescent interaction sequence.
- the salt's anion may be a phosphate, for example, but the use of other anions is also permissible in certain embodiments of the invention —once again, as long as the selected anion does not interfere with the electrochemiluminescent interaction sequence.
- the composition may also be nonaqueous. While supercritical fluids can in certain instances be employed advantageously, it is more typical to utilize an electro ⁇ lyte comprising an organic liquid in a nonaqueous compo ⁇ sition. Like an aqueous electrolyte, the nonaqueous electrolyte is also a phase through which charge is carried by ions. Normally, this means that a salt is dissolved in the organic liquid medium.
- suitable organic liquids are acetonitrile, dimethylsulfoxide (DMSO) , dimethylformamide (DMF) , methanol, ethanol, and mixtures of two or more of the foregoing.
- tetraalkylammonium salts such as tetrabutylammonium tetrafluoroborate, which are soluble in organic liquids can be used with them to form nonaqueous electrolytes.
- the electrolyte is, in certain embodiments of the invention, a buffered system.
- Phosphate buffers are often advantageous. Examples are an aqueous solution of sodium phosphate/sodium chloride, and an aqueous solution of sodium phosphate/sodium fluoride.
- a reductant typically an amine or amine moiety (of a larger molecule) which can be oxidized and spontaneously decomposed to convert it into a highly reducing species. It is believed that the amine or amine moiety is also oxidized by electrochemical energy introduced into the reaction system. The amine or amine moiety loses one electron, and then deprotonates, or rearranges itself, into a strong reducing agent. This agent interacts with the oxidized metal-containing ECL moiety and causes it to assume the excited state discussed above.
- a reductant typically an amine or amine moiety (of a larger molecule) which can be oxidized and spontaneously decomposed to convert it into a highly reducing species. It is believed that the amine or amine moiety is also oxidized by electrochemical energy introduced into the reaction system. The amine or amine moiety loses one electron, and then deprotonates, or rearranges itself, into a strong reducing agent. This agent interacts with the oxidized metal-containing E
- the amine or amine moiety preferably has a carbon-centered radical with an electron which can be donated from such carbon, and an alpha carbon which can then act as a proton donor during deprotonation in order to form the reductant.
- the amine-derived reductant provides the necessary stimulus for converting the metal- containing ECL moiety to its excited state, from which detectable electromagnetic radiation is emitted.
- amines and corresponding amine moieties can be utilized in practicing the present inven- tion.
- the amine or amine moiety is chosen to suit the pH of the system which is to be electrochemi- luminescently analyzed.
- Another relevant factor is that the amine or amine moiety should be compatible with the environment in which it must function during analysis, i.e., compatible with an aqueous or nonaqueous environ ⁇ ment, as the case may be.
- the amine or amine moiety selected should form an amine-derived reductant under prevailing conditions which is strong enough to reduce the oxidized metal-containing ECL moiety in the system.
- Amines (and corresponding moieties derived therefrom) which are advantageously utilized in the present invention are aliphatic amines, such as primary, secondary and tertiary alkyl amines, the alkyl groups of each having from one to three carbon atoms, as well as substituted aliphatic amines.
- Tripropyl amine is an especially preferred amine as it leads to, comparatively speaking, a particularly high-intensity emission of electromagnetic radiation, which enhances the sensitivity and accuracy of detection and quantitation with embodiments in which it is used.
- diamines such as hydrazine
- polymines such as poly(ethyleneimine) .
- Examples of other amines suitable for practicing the invention are triethanol amine, triethyl amine, l,4-diazabicyclo-(2.2.2)-octane, 1- piperidine ethanol, l,4-piperazine-bis-(ethane-sulfonic acid) , tri-ispropyl amine and poly(ethyleneimine) .
- the metal-containing ECL moiety utilized in the present invention is the reaction- limiting constituent. Accordingly, it is also typical that the amine or amine moiety is provided in a stoichiometric excess with respect thereto. Illustratively, the amine or amine moiety is employed in a concentration of 50-150 mM. For utilization at a pH of approximately 7, a concentration of 100 mM is often advantageous. In certain embodiments, the upper limit on amine or amine moiety concentration is determined by the maximum solubility of the amine or moiety in the environment in which it is being used, for example in water.
- the amount of amine or amine moiety employed is that which is sufficient to effect the transformation of the oxidized metal-containing ECL moiety into its excited state so that luminescence occurs.
- Those of ordinary skill in the art, equipped with the teachings herein, can determine empirically the amount of amine or amine moiety advantageously used for the particular system being analyzed, without undue experimentation.
- the assays of the invention are desirably carried out in the presence of an enhancer, typically a compound of the formula
- R is hydrogen or C n H n2+1
- R' is C n H 2n
- x is 0 to 70
- n is from 1 to 20.
- n is from 1 to 4.
- Specific examples are a substance available in commerce under the name Triton X-100, of the formula
- the enhancer is generally utilized in an amount sufficient so that in its presence the desired increase in emission of electromagnetic radiation occurs. Typically, the amount is .01% to 5.0%, more specifically 0.1% to 1.0%, v/v.
- the subject matter of this application is incorporated by reference.
- the ECL moiety incorporated in accordance with the present invention is induced to emit electromagnetic radiation by stimulating it into an excited state. This is accomplished by exposing the system in which the ECL moiety is incorporated to electrochemical energy.
- the potential at which oxidation of the ECL moiety and the species forming a strong reductant occurs depends upon the exact chemical structures thereof, as well as factors such as the pH of the system and the nature of the electrode used to introduce electrochemical energy. It is well known to those of ordinary skill in the art how to determine the optimal potential and emission wavelength of an electrochemiluminescent system. Certain preferred methods of stimulating the ECL system are disclosed in commonly assigned PCT published application US 89/01814, the contents of which are incorporated herein by reference.
- FIG. 1 discloses an advantageous ECL apparatus, but the methods of the present invention are not limited to application in apparatus 10, but rather may be employed in other types of ECL apparatus which include a working electrode or other triggering surface to provide electrochemical energy to trigger the ECL moiety into electrochemiluminescence. While the methods of the invention can be carried out in a static or flow-through mode, apparatus 10 includes a flow-through cell, which provides distinct advantages for many types of samples including binding assay samples. Further details of apparatus for carrying out the ECL assays of the invention are disclosed in commonly assigned published PCT applications US 89/04854 and U.S. 90/01370.
- Apparatus 10 includes an electrochemical cell 12, a light detection/measurement device 14, which may advantageously be a photomultiplier tube (PMT) , photodiode, charge coupled device, photographic film or emulsion or the like, and a pump 16, which is advantageously a peristaltic pump, to provide for fluid transport to, through and from cell 12. Alternatively, a positive displacement pump may be used.
- a shutter mechanism 18 is provided between cell 12 and PMT 14 and is controllably operated to open only so far as to expose PMT 14 to cell 12 during ECL measurement periods. The shutter mechanism may be closed, for example, during maintenance.
- a lightproof housing intended to mount the various components therein and to shield PMT 14 from any external light during the ECL measurements.
- Cell 12 itself includes a first mounting block
- Mounting block 20 through which passes an inlet tube 22 and an outlet tube 24, which may be advantageously constructed of stainless steel.
- Mounting block 20 has a first, outer surface 26 and a second, inner surface 28 defining one side of a sample-holding volume 30 of cell 12 in which cell 12 holds the cleaning and/or conditioning and/or measurement solutions during corresponding operations of apparatus 10.
- Inlet and outlet tubes 22, 24 pass through mounting block 20 from outer surface 26 to inner surface 28 and open into sample-holding volume 30.
- a second mounting block 32 advantageously constructed of stainless steel also has a first, outer surface 34 and a second, inner surface 36. Second mounting block 32 is separated from first mounting block 20 by an annular spacer 38, advantageously constructed of Teflon or other non-contaminable material.
- outer surface 34 of mounting block 30 defines part of the second side of the sample-holding volume 30.
- Spacer 38 has an outer portion 40 and a central aperture 42 whose inner edge 44 defines the side wall of sample-holding volume 30.
- Outer portion 40 seals the inner surface 28 of first mounting block 20 to outer surface 34 of second mounting block 32 to prevent any solution from passing out from sample-holding volume 30 between the two surfaces 28, 34.
- Mounting block 32 further has a central aperture 46 in which a window 48 is seal-fitted to define the rest of the second side of sample-holding volume 30 as a continuation of outer surface 34.
- Window 48 is formed of a material which is substantially transparent at the wavelength of electrochemiluminescent light emitted by the ECL moiety. Window 48 is therefore advantageously formed of glass, plastic, quartz or the like.
- Inlet tube 22 intersects sample-holding volume 30 at a first end 50 thereof adjacent to spacer 38 and outlet tube 24 intersects sample-holding volume 30 at a second end 52 thereof, adjacent spacer 38.
- the combination of inlet tube 22, sample-holding volume 30 and outlet tube 24 thereby provides a continuous flow path for the narrow, substantially laminar flow of a solution to, through and from cell 12.
- a working electrode system 54 which, in the illustrated embodiment, includes first and second working electrodes 56 and 58.
- a single working electrode may advantageously be provided, or only electrode 56 may be a working electrode.
- Working elec- trodes 56, 58 are where the electrochemical and ECL re ⁇ actions of interest can take place.
- Working electrodes 56, 58 are solid voltammetric electrodes and may therefore be advantageously constructed of platinum, gold, carbons or other materials which are effective for this purpose.
- Wire connectors 60, 62 connected to working electrodes 56, 58, respectively, pass out through first mounting block 20.
- Connectors 60, 62 are both connected to a first, "working electrode” terminal 64 of a voltage control 66, illustrated in Fig. 2.
- Voltage control 66 advantageously operates in the manner of a potentiostat to supply voltage signals to working electrodes 56, 58 and optionally to measure current flowing therefrom during an ECL measurement.
- connectors 60, 62 may be connected to separate terminals of voltage control 66 for individual operation. The potentiostat operation of voltage control
- counter electrode 66 is further effected through a counter electrode 68 and, optionally but advantageously, a reference electrode 70.
- mounting block 32 is made of stainless steel and counter electrode 68 consists in exposed surfaces 72, 74 of mounting block 32.
- Counter electrode 72, 74 and working electrodes 56, 58 provide the interface to impress the potential on the solution within sample-holding volume 30 which energizes the chemical reactions and triggers electrochemiluminescence in the sample and/or provides energy for cleaning and conditioning the surfaces of cell 12.
- Counter electrode 72, 74 is connected by a wire connector 76 to a second, "counter electrode" terminal 78 of voltage control 66.
- Reference electrode 70 provides a reference voltage to which the voltage applied by the working elec ⁇ trodes 56, 58 is referred, for example, +1.2 volts versus the reference.
- Reference electrode 70 is advantageously located in outlet tube 24 at a position 80 spaced from cell 12 and is connected through a wire connector 82 to a third "reference electrode" terminal 84 of voltage control 66. In the three electrode mode, current does not flow through reference electrode 70.
- Reference electrode 70 may be used in a three electrode mode of operation to provide a poised, known and stable voltage and is therefore advantageously constructed of silver/silver chloride (Ag/AgCl) or is a saturated calomel electrode (SCE) .
- Voltage control 66 may be operable in a two electrode mode of operation using only working electrode 56 and electrode 58 as a counter/reference electrode. In this two electrode mode of operation, counter/reference electrode 58 is electrically connected to voltage control terminals 78 and 84 on voltage control 66. In this case, voltage control 66 operates essentially as a battery. Voltage control 66 supplies voltage signals to working and counter electrodes 56 and 58 and optionally measures the current flowing through the respective electrodes.
- Reference electrode 70 may alternatively be a so-called “quasi-reference" electrode constructed of platinum, gold, stainless steel or other material, which provides a less stable voltage, yet one that is measurable with respect to the solution in contact.
- the reference electrode 70 or 58 serves the purpose of providing a reference against which the voltage applied to working electrodes 56 is measured.
- the poised voltage reference is currently considered to be more advantageous.
- Voltage control 66 in its potentiostat operation controls the various electrodes by providing a known voltage at working electrodes 56, 58 with respect to reference electrode 70 while measuring the current flow between working electrodes 56, 58 and counter electrode 72, 74.
- Potentiostats for this purpose are well known, and the internal structure of voltage control 66 may therefore correspond to any of the conventional, commercially available potentiostats which produce the above-recited functions and so do not form a part of the present invention per se.
- apparatus 10 may alternatively be constructed without an internal voltage control 66, and may be adapted to be connected to an external potentiostat which is separately controlled for providing the required voltage signals to electrodes 56, 58, 72, 74 and 70.
- These voltage signals applied in a specific manner as described below, provide repeatable initial conditions for the surfaces of working electrodes 56, 58 and advantageously for the surfaces of cell 12 as a whole, a feature which contributes significantly to improved precision in ECL measurements.
- Pump 16 is advantageously positioned at outlet tube 24 to "pull" solution from a sample volume in the direction of arrow A into inlet tube 22.
- the solution will flow through inlet tube 22, sample-holding volume 30 and outlet tube 24 past reference electrode 70 and out in the direction of arrow B.
- pump 16 may be positioned at inlet tube 22 to "push” the solution through apparatus 10.
- this same flow path through inlet tube 22, sample-holding volume 30 and outlet tube 24 is used for all solutions and fluids which pass through cell 12, whereby each fluid performs a hydrodynamic cleaning action in forcing the previous fluid out of cell 12.
- Pump 16 may be controlled to suspend its operation to hold a particular solution in cell 12 for any period of time.
- the flow-through construction of apparatus 10 permits working electrodes to be impressed with a variable voltage or to be continuously held at a preoperative potential while being continuously exposed to one or more solutions without exposing working electrodes 56, 58 (or counter and reference electrodes 72, 74, 70) to air. Exposure to air, which opens the circuit to the reference electrode 70, permits unknown, random voltage fluctuations which destroy the reproducibility of surface conditions on working electrodes 56, 58.
- the flow-through construction permits the rapid alternation between initializing steps, in which electrode system 54 is cleaned and conditioned, and measurement steps, in which one or more measurement waveforms or sweeps trigger ECL.
- the invention is also directed to reagent compositions.
- the reagent compositions may be any one of the components of the assay systems of the invention, i.e., (a) electrolyte, (b) label compound containing an ECL moiety, (c) functionalized fibrils to which an assay-performance-substance is bound, optionally bound to particles, including magnetically responsive particles, (d) analyte of interest or an analog of the analyte of interest, (e) a binding partner of the analyte of interest or of its analog, (f) a reactive component capable of reacting with (d) or (e) , (g) a reductant, or (h) an electrochemiluminescence-reaction enhancer.
- the reagents may be combined with one another for convenience of use, i.e., two component, three component, and higher multiple component mixtures may be prepared, provided that the components are not reactive with one another during storage so as to impair their function in the intended assay.
- the reagents are two- component or multicomponent mixtures which contain particles as well as one or more other components.
- kits may include vessels containing one or more of the components (a) to (h) recited above or the kits may con- tain vessels containing one or more reagent compositions as described above comprising mixtures of those components, all for use in the assay methods and systems of the invention.
- the functionalized fibrils of the invention can be directly prepared by sulfonation, electrophilic addition to deoxygenated fibril surfaces or metallation.
- arc grown nanofibers When arc grown nanofibers are used, they may require extensive purification prior to functionalization. Ebbesen et al. (Nature 367 519 (1994)) give a procedure for such purification.
- the carbon fibrils are processed prior to contacting them with the functionalizing agent.
- processing may include dispersing the fibrils in a solvent.
- the carbon fibrils may then be filtered and dried prior to further contact.
- Activated C-H (including aromatic C-H) bonds can be sulfonated using fuming sulfuric acid (oleum) , which is a solution of cone, sulfuric acid containing up to 20% S0 3 .
- the conventional method is via liquid phase at T ⁇ 80°C using oleum; however, activated C-H bonds can also be sulfonated using S0 3 in inert, aprotic solvents, or S0 3 in the vapor phase.
- the reaction is:
- a weighed sample of fibrils (BN or CC) in a porcelain boat was placed in the 1" tube fitted with a gas inlet; the outlet was connected to a cone. H 2 S0 4 bubbler trap. Argon was flushed through the reactor for 20 min to remove all air, and the sample was heated to 300°C for 1 hour to remove residual moisture. After drying, the temperature was adjusted to reaction temperature under argon.
- the liquid phase reaction was carried out in cone, sulfuric acid containing 20% S0 3 in a multi-neck 100 cc flask fitted with a thermometer/temperature controller and a magnetic stirrer. A fibril slurry in cone. H 2 S0 4 (50) was placed in the flask. The oleum solution (20 cc) was preheated to -60°C before addition to the reactor. After reaction, the acid slurry was poured onto cracked ice, and diluted immediately with 1 1 DI water. The solids were filtered and washed exhaustively with DI water until there was no change in pH of the wash effluent. Fibrils were dried at 100°C at 5" Hg vacuum. Due to transfer losses on filtration, accurate weight gains could not be obtained. Results are listed in Table I.
- the surface carbons in fibrils behave like graphite, i.e., they are arranged in hexagonal sheets containing both basal plane and edge carbons. While basal plane carbons are relatively inert to chemical attack, edge carbons are reactive and must contain some heteroatom or group to satisfy carbon valency. Fibrils also have surface defect sites which are basically edge carbons and contain heteroatoms or groups.
- the most common heteroatoms attached to surface carbons of fibrils are hydrogen, the predominant gaseous component during manufacture; oxygen, due to its high reactivity and because traces of it are very difficult to avoid; and H 2 0, which is always present due to the catalyst.
- Pyrolysis at -1000°C in a vacuum will deoxygenate the surface in a complex reaction with unknown mechanism, but with known stoichiometry.
- the products are CO and C0 2 , in a 2:1 ratio.
- the resulting fibril surface contains radicals in a C j - ⁇ alignment which are very reactive to activated olefins.
- the surface is stable in a vacuum or in the presence of an inert gas, but retains its high reactivity until exposed to a reactive gas.
- fibrils can be pyrolized at -1000°C in vacuum or inert atmosphere, cooled under these same conditions and reacted with an appropriate molecule at lower temperature to give a stable functional group.
- Typical examples are:
- RFS + CH 2 CH-CN > Fibril-R'CN where R' is a hydrocarbon radical (alkyl, cycloalkyl, etc.)
- the ends are fitted with a gas inlet/outlets.
- the tube is purged with dry, deoxygenated argon for 10 minutes, after which the temperature of the furnace is raised to 300°C and held for 30 minutes. Thereafter, under a continued flow of argon, the temperature is raised in 100°C increments to 1000°C, and held there for 16 hours. At the end of that time, the tube is cooled to room temperature (RT) under flowing argon. The flow of argon is then shunted to pass through a multi-neck flask containing neat purified acrylic acid at 50°C and fitted with gas inlet/outlets. The flow of acrylic acid/argon vapors is continued at RT for 6 hours.
- the resulting surface is very reactive and activated olefins such as acrylic acid, acryloyl chloride, acrylamide, acrolein, maleic anhydride, allyl amine, allyl alcohol or allyl halides will react even at room temperature to form clean products containing only that functionality bonded to the activated olefin.
- olefins such as acrylic acid, acryloyl chloride, acrylamide, acrolein, maleic anhydride, allyl amine, allyl alcohol or allyl halides
- Aromatic C-H bonds can be metaHated with a variety of organometallic reagents to produce carbon- metal bonds (C-M) .
- M is usually Li, Be, Mg, Al, or Tl; however, other metals can also be used.
- the simplest reaction is by direct displacement of hydrogen in activated aromatics: 1. Fibril-H + R-Li > Fibril-Li + RH
- the reaction may require additionally, a strong base, such as potassium t-butoxide or chelating diamines.
- a strong base such as potassium t-butoxide or chelating diamines.
- Aprotic solvents are necessary (paraffins, benzene) .
- TFA Trifluoroacetate
- HTFA Trifluoroacetic acid
- Fibril-M + X 2 > Fibril-X + MX X Halogen catalyst
- Preparation F Preparation of Fibril-Li
- CC fibrils is placed in a porcelain boat and inserted into a 1" quartz tube reactor which is enclosed in a Lindberg tube furnace. The ends of the tube are fitted with gas inlet/outlets. Under continuous flow of H 2 , the fibrils are heated to 700°C for 2 hours to convert any surface oxygenates to c-H bonds. The reactor is then cooled to RT under flowing H 2 .
- the hydrogenated fibrils are transferred with dry, de-oxygenated heptane (with LiAlH 4 ) to a 1 liter multi-neck round bottom flask equipped with a purified argon purging system to remove all air and maintain an inert atmosphere, a condenser, a magnetic stirrer and rubber septum through which liquids can be added by a syringe. Under an argon atmosphere, a 2% solution containing 5 mmol butyllithium in heptane is added by syringe and the slurry stirred under gentle reflux for 4 hours.
- the fibrils are separated by gravity filtration in an argon atmosphere glove box and washed several times on the filter with dry, deoxygenated heptane. Fibrils are transferred to a 50 cc r.b. flask fitted with a stopcock and dried under 10 ⁇ 4 torr vacuum at 50°C.
- the lithium concentration is determined by reaction of a sample of fibrils with excess O.IOON HCI in DI water and back-titration with O.IOON NaOH to an endpoint at pH 5.0. Preparation ⁇
- Preparation F are transferred with dry, deoxygenated heptane in an argon-atmosphere glove bag to a 50 cc single neck flask fitted with a stopcock and magnetic stirring bar.
- the flask is removed from the glove bag and stirred on a magnetic stirrer.
- the stopcock is then opened to the air and the slurry stirred for 24 hours.
- the fibrils are separated by filtration and washed with aqueous MeOH, and dried at 50°C at 5" vacuum.
- the concentration of OH groups is determined by reaction with a standardized solution of acetic anhydride in dioxane (0.252 M) at 80°C to convert the OH groups to acetate esters, in so doing, releasing 1 equivalent of acetic acid/mole of anhydride reacted.
- the total acid content, free acetic acid and unreacted acetic anhydride, is determined by titration with O.IOON NaOH to an endpoint at pH 7.5.
- triphenyl phosphine dissolved in dioxane 0.5 g triphenyl phosphine dissolved in dioxane is added.
- the slurry is stirred at 50°C for several minutes, followed by addition at 50°C of gaseous ammonia for 30 min.
- the fibrils are then separated by filtration, washed in dioxane, then DI water and dried at 80°C at 5" vacuum.
- the amine concentration is determined by reaction with excess acetic anhydride and back-titration of free acetic acid and unreacted anhydride with O.IOON NaOH. 3176 PC17US97/03653
- the graphitic surfaces of fibrils allow for physical adsorption of aromatic compounds.
- the attraction is through van der Waals forces. These forces are considerable between multi-ring heteronuclear aromatic compounds and the basal plane carbons of graphitic surfaces. Desorption may occur under conditions where competitive surface adsorption is possible or where the adsorbate has high solubility.
- the preferred compounds for physical adsorption on fibrils are derivatized porphyrins or phthalocyanine ⁇ which are known to adsorb strongly on graphite or carbon blacks.
- Several compounds are available, e.g., a tetracarboxylie acid porphyrin, cobalt (II) phthalocyanine or dilithium phthalocyanine. The latter two can be derivatized to a carboxylic acid form.
- the loading capacity of the porphyrin or phthalocyanines can be determined by decoloration of solutions when they are added incrementally.
- the deep colors of the solutions deep pink for the tetracarboxylic acid porphyrin in MeOH, dark blue-green for the Co(II) or the dilithium phthalocyanine in acetone or pyridine
- Loading capacities were estimated by this method and the footprints of the derivatives were calculated from their approximate measurements (-140 sq. Angstroms) . For an average surface area for fibrils of 250 m 2 /g, maximum loading will be -0.3 mmol/g.
- the fibril slurries were initially mixed (Waring blender) and stirred during loading. Some of the slurries were ultra-sounded after color was no longer discharged, but with no effect. After loading, Runs 169-11, -12, -14 and -19-1
- Runs 168-18 and -19-2 used the calculated amounts of pigment for loading and were washed only very lightly after loading.
- the tetracarboxylic acid porphyrin (from acetone) and the Co phthalocyanine (from pyridine) were loaded onto fibrils for further characterization (Runs 169-18 and —19-2, respectively).
- a number of substituted polynuclear aromatic or polyheteronuclear aromatic compounds were adsorbed on fibril surfaces.
- the number of aromatic rings should be greater than two per rings/pendant functional group.
- substituted anthracenes, phenanthrenes, etc., containing three fused rings, or polyfunctional derivatives containing four or more fused rings can be used in place of the porphyrin or phthalocayanine derivatives.
- substituted aromatic heterocycles such as the quinoline ⁇ , or multiply substituted heteroaromatics containing four or more rings can be used.
- Table II summarizes the results of the loading experiments for the three porphyrin/phthalocyanine derivatives " .
- the sample of CC fibrils was slurried in cone. H 2 S0 4 by mixing with a spatula and then transferred to a reactor flask fitted with gas inlet/outlets and an overhead stirrer. With stirring and under a slow flow of argon, the charge of NaC10 3 was added in portions at RT over the duration of the run. Chlorine vapors were generated during the entire course of the run and were swept out of the reactor into a aqueous NaOH trap. At the end of the run, the fibril slurry was poured over cracked ice and vacuum filtered. The filter cake was then transferred to a Soxhlet thimble and washed in a Soxhlet extractor with DI water, exchanging fresh water every several hours. Washing was continued until a sample of fibrils, when added to fresh DI water, did not change the pH of the water. The fibrils were then separated by filtration and dried at 100°C at 5" vacuum overnight.
- the carboxylic acid content was determined by reacting a sample with excess O.IOON NaOH and back- titrating with 0.100 n HCI to an endpoint at pH 7.5. The results are listed in Table III.
- a weighed sample of fibrils was slurried with nitric acid of the appropriate strength in a bound bottom multi-neck indented reactor flask equipped with an overhead stirrer and a water condenser. With constant stirring, the temperature was adjusted and the reaction carried out for the specified time. Brown fumes were liberated shortly after the temperature exceeded 70°C, regardless of acid strength. After the reaction, the slurry was poured onto cracked ice and diluted with DI water. The slurry was filtered and excess acid removed by washing in a Soxhlet extractor, replacing the reservoir with fresh DI water every several hours, until a slurried sample gave no change in Ph from DI water. The fibrils were dried at 100°C at 5" vacuum overnight.
- the number of secondary derivatives which can be prepared from just carboxylic acid is essentially limitless. Alcohols or amines are easily linked to acid to give stable esters or amides. If the alcohol or amine is part of a di- or poly-functional molecule, then linkage through the O- or NH- leaves the other functionalities as pendant groups.
- Typical examples of secondary reagents are:
- R alkyl, aralkyl, R- Methanol, phenol, tri- aryl, luoroethanol, fluorocarbon, OH-ter inated polymer, SiR' 3 Polyester, silanols
- H 2 N- Ethylenediamine polyethyl- aralkyl eneamines
- the reactions can be carried out using any of the methods developed for esterifying or aminating carboxylic acids with alcohols or amines.
- the methods of H.A. Staab, Angew. Chem. Internet. Edit., (l) , 351 (1962) using N,N'-carbonyl diimidazole (CDI) as the acylating agent for esters or amides and of G.W. Anderson, et al., J. A er. Chem. Soc. 86, 1839 (1964), using N-Hydroxysuccinimide (NHS) to activate carboxylic acids for amidation were used.
- CDI N,N'-carbonyl diimidazole
- NHS N-Hydroxysuccinimide
- Amidation of amines occurs uncatalyzed at RT.
- the first step in the procedure is the same. After evolution of C0 2 , a stoichiometric amount of amine is added at RT and reacted for 1-2 hours. The reaction is quantitative.
- the reaction is:
- N-Hvdroxvsuccinimide Activation of carboxylic acids for amination with primary amines occurs through the N- hydroxysuccinamyl ester; carbodiimide is used to tie up the water released as a substituted urea.
- the NHS ester is then converted at RT to the amide by reaction with primary amine. The reactions are:
- Diaza-l,l,l-bicyclooctane (DABCO) are used as catalysts.
- Suitable solvents are dioxane and toluene.
- ethylenediamine 100 ⁇ l ethylenediamine (en) was added to 10 ml 0.2 M NaHC0 3 buffer. An equivalent volume of acetic acid (HOAc) was added to maintain the pH near 8. NHS- activated oxidized fibrils (0.310 g) was added with vigorous stirring and reacted for l hr. An additional 300 ⁇ l of en and 300 ⁇ l HOAc was added for an additional 10 min. The solution was filtered on 0.45 micron polysulfone membrane and washed successively with NaHC0 3 buffer, 1% HCI, DI water and EtOH. The solids were dried under vacuo overnight. The HCI salt was converted back to the free amine by reaction with NaOH (177-046-1) for further analysis and reactions.
- HOAc acetic acid
- ESCA was carried out to quantify the amount of N present on the aminated fibrils (GF/NH 2 ) .
- ESCA analysis of 177-046-1 showed 0.90 at% N (177-059).
- a derivative was made by the gas phase reaction with pentafluorobenzaldehyde to produce the corresponding Schiff Base linkages with available primary amine groups.
- ESCA analysis still showed the 0.91 at% N, as expected, and 1.68 at%F. This translates into a 0.34 at% of N present as reactive primary amine on the aminated fibrils (5 F per pentafluorobenzaldehyde molecule) .
- a level of 0.45 at% N would be expected assuming complete reaction with the free ends of each N. The observed level indicates a very high yield from the reaction of N with NHS-activated fibril and confirms the reactivity of the available free amine groups.
- Acid functionalized fibrils prepared as in Preparation K were slurried in dioxane in an inert atmosphere. With stirring, a stoichiometric amount of chlorotriethyl silane was added and reacted for 0.5 hr, after which several drops of a 5% solution of DABCO in dioxane was added. The system was reacted for an additional hour, after which the fibrils were collected by filtration and washed in dioxane. The fibrils were dried at 100°C in V" vacuum overnight.
- Table V summarizes the secondary derivative preparations. The products were analyzed by ESCA for C, O, N, Si and F surface contents. TABLE V
- Acid functionalized fibrils prepared as in Preparation K are slurried in dioxane in an inert atmosphere. With stirring, a stoichiometric amount of chlorotriethyl silane is added and reacted for 0.5 hr, after which several drops of a 5% solution of DABCO in dioxane is added. The system is reacted for an additional hour, after which the fibrils are collected by filtration and washed in dioxane. The fibrils are dried at 100°C in 5" vacuum overnight.
- Table VI summarizes the secondary derivative preparations. Products are analyzed by ESCA. The analysis confirms the incorporation of the desired pendant groups. The products are analyzed by ESCA for C, O, N, Si and F surface contents.
- A can be further reacted to yield secondary derivatives .
- Sulfonic acids can be reduced to mercaptans by LiAlH or the combination of triphenyl phosphine and iodine (March,
- Dilithium phthalocyanine In general, the two
- Li + ions are displaced from the phthalocyanine (Pc) group by most metal (particularly multi-valent) complexes.
- Cobalt (II) complexes are particularly suited for this.
- Co ++ ion can be substituted for the two Li + ions to form a very stable chelate.
- the Co ++ ion can then be coordinated to a ligand such as nicotinic acid, which contains a pyridine ring with a pendant carboxylic acid group and which is known to bond preferentially to the pyridine group.
- a ligand such as nicotinic acid, which contains a pyridine ring with a pendant carboxylic acid group and which is known to bond preferentially to the pyridine group.
- Co(II)Pc can be electrochemically oxidized to Co(III)Pc, forming a non-labile complex with the pyridine moiety of nicotinic acid.
- the free carboxylic acid group of the nicotinic acid ligand is firmly attached to the fibril surface.
- Suitable ligands are the aminopyridines or ethylenediamine (pendant NH 2 ) , mercaptopyridine (SH) , or other polyfunctional ligands containing either an amino- or pyridyl- moiety on one end, and any desirable function on the other.
- 3-DIMENSIONAL STRUCTURES The oxidized fibrils are more easily dispersed in aqueous media than unoxidized fibrils. Stable, porous 3-dimensional structures with meso- and macropores (pores >2 nm) are very useful as catalysts or chromatography supports. Since fibrils can be dispersed on an individualized basis, a we11-dispersed sample which is stabilized by cross-links allows one to construct such a support. Functionalized fibrils are ideal for this application since they are easily dispersed in aqueous or polar media and the functionality provides cross-link points. Additionally, the functionality provides points to support the catalytic or chromatographic sites.
- the end result is a rigid, 3-dimensional structure with its total surface area accessible with functional sites on which to support the active agent.
- Typical applications for these supports in catalysis include their use as a highly porous support for metal catalysts laid down by impregnation, e.g., precious metal hydrogenation catalysts.
- the ability to anchor molecular catalysts by tether to the support via the functionality combined with the very high porosity of the structure allows one to carry out homogeneous reactions in a heterogeneous manner.
- the tethered molecular catalyst is essentially dangling in a continuous liquid phase, similar to a homogeneous reactor, in which it can make use of the advantages in selectivities and rates that go along with homogeneous reactions.
- being tethered to the solid support allows easy separation and recovery of the active, and in many cases, very expensive catalyst.
- the 3-dimensional structure of functionalized fibrils is an electrode, or part of an electrode, and the functionalization has resulted from adsorption of Co(II)Pc
- electrochemical oxidation of Co(II) to Co(III) in the presence of nicotinic acid will produce a non- labile Co(III)-pyridyl complex with a carboxylic acid as the pendent group.
- Attaching a suitable antigen, antibody, catalytic antibody, or other site-specific trapping agent will permit selective separations of molecules (affinity chromatography) which are otherwise very difficult to achieve.
- the Co(III) complex containing the target molecule can be electrochemically reduced to recover the labile Co(II) complex.
- the ligand on Co(II) containing the target molecule can then be recovered by mass action substitution of the labile Co(II) ligand, thereby effecting a separation and recovery of molecules which are otherwise very difficult or expensive to perform (e.g., chiral drugs).
- Another example of 3-dimensional structures are fibril-ceramic composites.
- nitric acid oxidized fibrils (173-83- 03) were highly dispersed on 200 cc ethanol using ultrasonification.
- a solution of 0.1 mol tetraethoxysilane dissolved in 50 cc ethanol was slowly added to the slurry at RT, followed by 3 cc cone. HCL.
- the mixture was heated to 85°C and maintained at that temperature until the volume was reduced to 100 cc.
- the mixture was cooled and set aside until it formed a black solid gel. The gel was heated at 300°C in air.
- silica-fibril composites were examined by SEM. Micrographs of cracked surfaces showed a homogeneous dispersion of fibrils in the gel. Similar preparations with other ceramics, such as zirconia, titania, rare earth oxides as well as ternary oxides can be prepared.
- the invention has application in the formulation of a wide variety of functionalized nanotubes.
- nanotubes While a wide range of nanotubes can be employed in the assays of the invention, generally the nanotubes have a density of from 1.0 to 5.0 g/mL and preferably have a density of from 1.1 to 2 g/mL. Choice of the optimum density is within the skill of the art, the rate of settling in gravity-driven assays being a trade-off between the speed of the assay and the desire to create a uniform layer of complex on the electrode surface.
- Nanotubes having a wide range of mean diameters can also be employed. Particles having a mean diameter of from 0.001 to 100 ⁇ m can be used and preferably the particles have a mean diameter of from 0.01 to 10 ⁇ m. Lengths of the nanotubes are at least five times the diameter. Wide ranges of concentration of particles in the assay composition can also be employed. For example, the concentration can range from 1 x IO" 9 to 1 x 10 ⁇ 2 g/mL to preferably from 1 x 10 ⁇ 8 to 1 x 10" 3 g/mL. Desirably, the density of the particles, their size and their concentration is selected such that the particles settle at a rate of at least 0.5 mm/min and preferably at a faster rate. In the filtration mode of performing the invention, the filtration means desirably has a pore size, measured as mean diameter, from broadly 0.01 to 90% of the mean diameter of the particles and preferably from 10% to 90% of that diameter.
- the nanotubes may be paramagnetic or ferromagnetic and may be coated with various materials to which binding compounds are coupled so that the magnetic particle can be used in assays.
- the magnetic nanotubes used in the invention have a susceptibility of at least 0.001 cgs units and desirably the susceptibility is at least 0.01 cgs units.
- the magnetic nanotubes may have a broad range of densities, i.e. from substantially less than that of water, 0.01, to 5 g/mL and preferably from 0.5 to 2 g/mL.
- the particle sizes can range from 0.001 to 100 ⁇ m and preferably from 0.01 to 10 ⁇ m.
- the concentration of the particles may range broadly from 1 x 10" 9 to l x 10 ⁇ 2 g per mL and preferably is from 1 x IO "8 to 1 x 10 ⁇ 3 g per mL.
- the magnetic nanotubes which are used have a low magnetic remanence, as described for example EP 0,180,384, so that after the magnetic field is removed from the electrode surface, the nanotubes demagnetize and can be swept out of the assay cell.
- the density, concentration and size of the magnetic nanotubes is chosen such that the settling time is at least 0.5 mm/min and desirably it is above that rate. In operation of the magnetic cell it is often desirable to remove the magnet means from the electrode surface prior to inducing electrochemiluminescence in order not to interfere with the operation of the photomultiplier tube. Assays
- a variety of assays can be performed using the methods of the invention.
- An assay was conducted using functionalized carbon nanotubes.
- the assay involved an ECL detection of hydrolytic enzymes using carbon nanotubes (fibrils) .
- Carbon nanotubes (fibrils) were chemically modified with substrates of hydrolytic enzymes.
- On the end of the substrate farthest from the fibril was attached a derivative of Ru(bpy) 3 2+ .
- the general structure of the solid phase was as follows: fibril-substrate (scissile bond)-Ru(bpy) 3 2+ . If an enzyme is present that cleaves the scissile bond, the Ru(bpy) 3 2+ end of the substrate is released into solution by the action of the enzyme.
- the assay is a novel ECL assay for proteases because it does not involve antibodies (it is not an immunoassay) . Thus, it has the advantage of being an assay for enzyme activity rather than an assay for the enzyme's presence (the enzyme may be inactive) . Moreover, the assay uses fibrils as a solid support.
- Fibrils are attractive because of their high surface area and amenability in attaching biomolecules such as enzyme substrates.
- the functionalized fibrils may be formed into a flow through membrane (mat) .
- the enzyme mixture could rapidly flow through to release Ru(bpy) 3 2+ and make the assay rapid and convenient.
- a DNA probe assay using fibrils and ECL was conducted. Carbon nanotubes (fibrils) were used as a solid support in DNA probe assays as a separation media to separate analyte from complex mixtures which may include biological fluids and added reagents. Fibrils were modified with avidin (or streptavidin) , either by covalent attachment (via NHS ester) or by adsorption to alkyl fibrils. Biotinylated ssDNA (the "analyte”) bound to the avidin fibrils and was detected by the ECL of a complementary single stranded oligonucleotide which had been labeled with Ru(bpy) 3 2+ .
- One format for detecting a natural (non- biotinylated) DNA fragment is a competitive format where the Ru(bpy) 3 2+ -labeled oligo can bind to either the natural DNA or to an introduced biotinylated DNA.
- the more analyte that is present (non-biotinylated DNA) the less labeled oligo remains to bind to the biotinylated DNA, which when captured on avidin fibrils gives an ECL signal.
- carbon nanotubes have a very high surface area which means that less solid support is necessary than with other solid supports.
- Fibrils are electrically conductive, which is an attractive property for a solid support in ECL applications, in which the solid support rests against an electrode. Being electrically conductive, more of the surface area is in electrochemical contact than with other supports which are not conductive.
- Antibody fibrils could be used in ECL applications in a competitive immunoassay format (where there is a competition between the analyte and Ru(bpy) 3 2+ - labeled analyte for binding to the antibody fibrils) or in a sandwich format (where a Ru(bpy) 3 2+ -labeled secondary antibody binds to the antibody fibril-analyte complex) . In both cases, ECL light emission signals the presence or absence of the analyte of interest.
- Antibody can be immobilized on fibrils by several different methods, by covalent or non-covalent means.
- antibody is adsorbed onto unmodified fibrils or onto fibrils modified to enhance adsorption characteristics.
- modified fibrils have hydrophobic appendages (alkyl chains or pheny1-alkyl chains) .
- Covalent immobilization of antibodies onto fibrils can be achieved by three different methods: by NHS ester activation of carboxylated fibrils, by reductive a ination of antibody carbohydrate groups, and by sulfhydryl/maleimido fibrils reacting with reduced or maleimido-modified antibodies.
- the immobilization of antibodies on carbon fibrils is advantageous.
- Antibody fibrils have a number of unique properties compared with other solid supports for antibodies. These advantages include high surface area per weight, electrical conductivity (especially in ECL applications) , and chemical and physical stability.
- Carbon nanotubes were used as ECL-based biosensors.
- Bifunctional fibrils were prepared wherein a derivative of the enzyme cofactor NAD+ was attached to one functional group and a derivative of Ru(bpy) 3 2+ was attached to the other functional group (COOH) .
- the biosensor fibrils were mixed with a solution that contained the analyte (a dehydrogenase, in this case G6PDH) and the substrate of the dehydrogenase was added (in this case, glucose-6-phosphate) .
- the ECL of the fibrils were measured in an ECL instrument.
- a change in the ECL properties of the biosensor fibrils indicated the presence of the enzyme, G6PDH.
- the following advantages were found: (1) The close proximity of the NAD+ and Ru(bpy) 3 + coreactants results in an intramolecular ECL reaction which is more efficient than intermolecular ECL reactions. (2) The ECL active reagents (the NAD+ and Ru(bpy) 3 2+ coreactants) are immobilized on fibrils, which allows them to settle or be magnetically drawn to the ECL electrode, resulting in enhanced light emission. (3) Fibrils have an extremely high surface area, such that large amounts of the coreactants (NAD+ and Ru(bpy) 3 2+ can be immobilized, theoretically enhancing light output during detection of dehydrogenases.
- Fibrils are electrically conductive - when the biosensors reach the electrode, much of their surface area which is not in actual contact with the electrode can receive voltage and participate in ECL reactions.
- the biosensor is designed to detect dehydrogenases that use either NAD+ or NADH as a cofactor. Many of these enzymes exist and could be detected using this invention.
- Carbon fibrils were used as a solid support for an enzyme biosensor. Because the enzyme biosensor is water soluble, it can only be used once, unless it is immobilized (immobilization allows it to be recovered from the analyte solution).
- U.S. Application Serial No. 08/467,712 discusses and claims immobilization to a solid support and to a (solid) electrode. The present application demonstrates the use of carbon fibrils as the solid support.
- the enzyme biosensor can be attached to fibrils by adsorption.
- the fibrils may either be unmodified fibrils or, preferably, chemically modified fibrils. Chemical modification of the fibrils is preferably by alkylation. Adsorption of the biosensor is carried out by incubation with mixing of the enzyme biosensor and the alkylated fibrils.
- Fibrils as a solid support are novel and attractive because: (1) they have a high surface area of immobilization resulting in potentially high light emission, (2) proteins such as the biosensor can be conveniently adsorbed without covalent chemistry, (3) fibrils are electrically conductive which may enhance ECL when in contact with an electrode, (4) fibrils themselves may be made into electrodes, in which case the electrode itself if a biosensor support.
- Magnetically-susceptible particles are useful as devices for separations. Separations of, for example, a specific analyte from a complex mixture are useful in the diagnostics industry where an analyte may be present in a complex mixture such as blood. Because the complex mixture may interfere with the analysis of the analyte, it is desirable to bind the analyte to a solid surface so that the complete mixture can be washed away from the analyte, thus allowing its determination. If the desired analyte can specifically bind to a magnetically- susceptible particle, that particle can be held by a magnet, allowing washing of the complex mixture away from the analyte, which can then be detected.
- fibrils are particles that can specifically and efficiently bind biomolecules
- magnetically-susceptible fibrils advantageously are used as solid phase separation devices, especially in ECL analyses.
- Fibrils were made magnetically-susceptible by performing treatments, such as chemical reactions or changes of the solvent that they are suspended in (for example, from water to DMF) . It is speculated that such manipulations cause changes in the physical aggregation of multiples of fibrils. Because fibrils have some (approximately 0.5% by weight) iron in them, they have the ability, once aggregated, to be substantially magnetically susceptible. Several treatments were carried out which increase the magnetic susceptibility of fibrils.
- Magnetically-susceptible fibrils have at least two unique advantages. First, they have a very high surface area per weight. Thus, less fibrils need to be used (as compared to for example Dynal beads) to achieve the same result. Secondly, fibrils are electrically conductive. Thus, they have an advantage in applications such as ECL where the magnetically susceptible particles are held to an electrode. Thus, being electrically conductive, they actually become part of the electrode, enhancing the light output efficiency.
- a flow-through apparatus employing three elec ⁇ trodes, as described in Figs. 1 and 2, was used.
- Inlet Tubing .042" id polypropylene Aspiration Rates:variable from 0.01 to 5 mL/min Potentiostat: microprocessor controlled Luminometer using Hamamatsu R374 PMT (low gain red sensitive tube) ; PMT Voltage variable 0-1400 V (2) ECL Measurement cycle (three electrode cell operation)
- the ECL measurement cycle consists of three steps: (1) preconditioning, (2) measuring, and (3) cleaning.
- the preconditioning step involves the application of a voltage triangle wave of 0.0 V to +2.2 V to -1.0 V to +0.6 V at 2.0 V/sec.
- the measurement step involves the application of a triangle waveform from +0.6 V to +2.8 V to +2.0 V at 1.0 V/s.
- the cleaning step involves the application of a voltage square wave from +0.0 V to +3.0 V to -0.5 V to 0.0 V. All voltages are relative to the Ag/AgCl reference electrode.
- Tetrapeptide of FmocNH-Gly-Lys(N ⁇ -CBZ)-Phe-Gly-COOH was synthesized by conventional solution phase methods and this peptide (71 mg, 0.093 mmol) was reacted with a primary amine derivatized version of Ru(bpy) 3 2+ (IGEN, Inc., Gaithersburg, MD) (73 mg, 0.078 mmol), EDC (17.8 mg, 0.093 mmol) was used as a activating reagent, and HOBT (12.58 mg, 0.093 mmol) as a catalyst.
- TMSI trimethylsilyl iodide
- IGEN standard ECL assay buffer IGEN, Inc. , Gaithersburg,
- a Ru(bpy) 3 2+ -labeled tetrapeptide (NH 2 -Gly-Lys- Phe-Gly-Ru(bpy) 3 2+ ) was conjugated to carboxylated fibrils a.s described in Example 1.
- the Ru(bpy) 3 2+ -labeled peptide fibrils (RPF) were used to detect the activity of the hydrolytic enzymes trypsin and chymotrypsin.
- the RPF were added to an aqueous solution containing either or both of the enzymes. Because the peptide was designed to contain specific cleavage sites for both trypsin and chymotrypsin (Fig.
- Such enzymes include: nucleases (using fibrils conjugated to Ru(bpy) 3 2+ -labeled RNA, single stranded DNA, or double stranded DNA) , glycosidases (using fibrils conjugated to Ru(bpy) 3 2+ -labeled sugars, oligosaccharides, or polysaccharides) , or lipases (using fibrils conjugated to Ru(bpy) 3 2+ -labeled lipids) .
- Buffer IGEN, Inc., Gaithersburg, MD
- the suspensions were rotated at room temperature. Periodically, the rotation was stopped, the suspension was quickly centrifuged, and the ECL of the aqueous supernatant was measured.
- the DNA probe assay is depicted in Figure 4.
- One tube of (strept)avidin fibrils was mixed with 4 ⁇ l of 4 nM biotinylated DNA (70 nucleotides) that was bound to a ruthenium tag labeled oligomer.
- the other tube was added with 4 ⁇ l of ruthenium tag labeled oligomer (same concentration as in the biotinylated DNA sample) only for a control assay.
- the reaction mixtures were incubated at room temperature for 15 minutes and washed seven times with 300 ⁇ l of ORIGEN assay buffer (IGEN, Inc., Gaithersburg, MD) .
- the fibrils were then suspended in 600 ⁇ l ORIGEN assay buffer and aliquoted to two tubes for duplicate ECL counting, using gravity capture of the fibrils.
- the result of the ECL assay were summarized as follows: sample ECL count avidin fibrils (control) 161 avidin fibrils (DNA probe) 2212 streptavidin fibrils (control) 885 streptavidin fibrils (DNA probe) 4248
- ECL count was 3835 for avidin fibril DNA probe verses 205 for the control.
- the object of the example is to immobilize antibodies on the surfaces of carbon nanotubes.
- Such antibody-modified nanotubes can be used in various applications including immunoassay detection of specific analytes and biospecific affinity separations.
- Immunoassays could be carried out using antibody-modified nanotubes as a solid support.
- Use of a solid support allows for washing steps if the solid support is either fixed, or otherwise separated from the solution phase (by for instance, filtration, centrifugation, or magnetism) .
- Use of wash steps would permit the use of antibody- modified nanotubes in many types of electrochemiluminescence-based immunoassays.
- the antibody-modified nanotubes could be used as replacements of the conventionally-used magnetic beads, or as a suspendible support capable of capture by filtration, or as a permanently-fixed support ion a disposable cartridge.
- NHS ester fibrils (84.5 mg) were pre-treated with 1.0 mL coupling buffer (0.2 M NaHC0 3 , pH 8.1), then suspended in another 1.0 mL of coupling buffer (0.1 M sodium phosphate, 0.5 M NaCl, pH 7.5). Monoclonal antibody (anti-glucose oxidase) (1.5 mg in 2.0 mL of coupling buffer) was added to the fibrils and the suspension was rotated for 1 hour to allow the NHS fibrils to react with the antibody (primarily with lysine sidechains of the antibody) . The resulting fibrils were filtered and repeatedly washed with coupling buffer.
- Non-antibody coated sites on antibody-modified fibrils were blocked by rotation for 10 minutes with 1% BSA dissolved in phosphate-buffered saline solution, pH 6.0. Glucose oxidase was dissolved in the BSA solution and this solution was mixed with the fibrils for 1.5 hours. Finally, the fibrils were washed with neutral pH phosphate buffer until no protein was observed to elute by spectrophotometrically monitoring the effluents at 280 nm.
- Glucose oxidase activity was spectrophotometrically-determined by adding a sample of the enzyme (either free enzyme or enzyme specifically bound to antibody-modified fibrils) to a cuvette containing 0.1 M sodium phosphate (pH 6.0), 20 ⁇ M glucose, 183 nM horseradish peroxidase, and 30 ⁇ M 2,2'- azino-bis(3-ethylbenzthiazoline-6-sulfonic acid (ABTS) .
- the activity of glucose oxidase was measured by spectrophotometrically determining the rate of absorbance increase at 414 nm at 25°C (formation of green color) .
- Functional antibody molecules on the fibrils were quantitated by the catalytic activity of bound antigen, glucose oxidase as described above.
- DTT dithiothreitol
- the reduced antibody was purified using a PD-10 disposable gel filtration column (Pharmacia) .
- HRP Horseradish Peroxidase
- Mouse antibody fibrils were pre-incubated with 0.1% PEG in sodium phosphate buffer (0.1 M, pH 7.5, 1 ml) for 30 minutes at 40°C. They were then centrifuged and the supernatant was removed. Mouse antibody fibrils were incubated with HRP-labeled goat anti-mouse antibody (0.01 mg) in sodium phosphate buffer (0.1 M, pH 7,5, 500 ml) containing 0.1% PEG for 2 hours at room temperature. The fibrils were then washed five times with 0.1% PEG in sodium phosphate buffer (0.1 M, pH 7.5, 1 ml). The amount of bound HRP was determined by spectrophotometrically measuring the catalytic activity of the bound enzyme. The enzyme reaction is shown below:
- N ⁇ -CBZ-N e - (tert-butoxycarbony1)-L-lysine was treated with 0.2 M calcium carbonate (4 ml) and the aqueous layer was removed to obtain a white solid.
- the solid was resuspended in N,N- dimethylformamide(40 ml) and benzyl bromide (1.16 ml). The reaction mixture was stirred overnight at room temperature. The reaction mixture was worked up with ethyl acetate and water, and the organic layer was dried over magnesium sulphate.
- N ⁇ -CBZ-N 6 -(tert-butoxycarbonyl)-L-lysine benzyl ester which was purified by silica gel chromatography using 25% hexane in ethyl acetate as a solvent.
- N ⁇ -CBZ-N e -(tert-butoxycarbonyl)-L-lysine benzyl ester (1 g, 2.2 mmol) in methylene chloride (10 ml) was added trifloroacetic acid at 0°C.
- the reaction mixture was stirred for 10 minutes at 0°C, then stirred for further 2.5 hr at room temperature.
- the solvent was removed and the crude product was obtained. Pure N ⁇ - CBZ-L-lysine benzyl ester was obtained by silica gel chromatography.
- N ⁇ -CBZ-L-lysine benzyl ester fibrils 113 mg
- sodium hydroxide I N, 4 ml
- the product N ⁇ -CBZ-L-lysine fibrils was extensively washed with water and methanol and the fibrils were dried under vacuum.
- the final bifunctional fibrils were extensively washed with water, methanol, 0.5 N sodium hydroxide, acetonitrile and methylene chloride. Amino acid analysis showed 0.3 ⁇ mols lysine per gram of fibrils.
- Hydroxyl and carboxyl (or amino) bifunctional fibrils can be made by a similar method to that described here by using serine, threonine, or tyrosine.
- Thiolated and carboxyl (or amino) bifunctional fibrils can be made using cysteine.
- Carboxyl and amino bifunctional fibrils can be made using aspartic or glutamic acid.
- the fibrils were suspended in a mixture of ethanol (4 ml) and water (4 ml) and cis-dichlorobis (2,2'-bipyridine) ruthenium (II) dihydrate (45.2 mg, 0.087 mmol) was added. The mixture was refluxed for 5.5 hours at 110°C. The ruthenium complex-modified fibrils were extensively washed with water, standard ECL assay buffer (IGEN, Inc. , Gaithersburg, MD) , toluene, 50% dioxane in water, then sequentially refluxed in acetonitrile, ethylene glycol and methanol.
- standard ECL assay buffer IGEN, Inc. , Gaithersburg, MD
- the ruthenium complex-modified fibrils were reacted with TMSI (4 ml) in acetonitrile (4 ml) for 4 hours at 40°C to deprotect the CBZ group, then washed with methanol, water, and sodium hydroxide (I N). The final produce was dried under vacuum.
- the fibrils were then suspended in methylene chloride (5 ml) and triethylamine (5 drops) was added. To the suspension was added succinic anhydride (40 mg) . The reaction mixture was stirred overnight at room temperature and the product was washed with methylene chloride, methanol, and water, then dried under vacuum.
- the carboxylic acid/ruthenium complex-modified fibrils were resuspended in dioxane (5 ml) , then N-hydroxysuccinimide (100 mg) and EDC (167 mg) were added. The reaction mixture was stirred for 4 hours at room temperature. The resulting NHS ester/ruthenium complex-modified fibrils were washed with dioxane and methanol. The NHS ester/ruthenium complex-modified fibrils were resuspended in dioxane (2 ml) and a solution of NAD analog in sodium bicarbonate (75 ml in 2 ml of 0.2 M pH 8.6 NaHC0 3 ) was added. The reaction mixture was stirred overnight at room temperature. The fibrils were then extensively washed with water, sodium bicarbonate (0.2 M) , and methanol, then dried under the vacuum to obtain the biosensor fibrils.
- An ECL-based biosensor was prepared by chemical modification of fibrils.
- the modified fibrils were prepared using NH /COOH bifunctional fibrils (Example 8) .
- To one functional group (NH 2 ) was added an NAD + analog and to the other functional group (COOH) was added a derivative of Ru(bpy) 3 2+ .
- the structure of the biosensor fibrils is shown in Figure 7.
- the biosensor was designed to facilitate detection of dehydrogenase enzymes that accept NAD(P) + /NAD(P)H as a cofactor and substrates of dehydrogenase enzymes that accept NAD(P) + /NAD(P)H as a cofactor. It is known (E. Jameison et al.. Analytical Chemistry, in press) that NAD(P) + and NAD(P)H have dramatically different abilities to promote Ru(bpy) 3 2+ ECL.
- the activity of a dehydrogenase can be detected by its ability to reduce/oxidize NAD(P) + /NAD(P)H, which is observable by differences in the abilities of NAD(P) + and NAD(P)H to cause Ru(bpy) 3 2+ electrochemiluminescence ( Figure 8) .
- the action of dehydrogenases on their substrates is stoichiometrically accompanied by conversion of NAD(P) + to NAD(P)H or NAD(P)H to NAD(P) + , the presence of their substrates can also be detected by electrochemiluminescence.
- the biosensor is mixed with an aqueous solution containing a dehydrogenase and an unknown quantity of the dehydrogenase's substrate (the substrate is the analyte) or an aqueous solution containing a dehydrogenase substrate and an unknown quantity of dehydrogenase (the dehydrogenase is the analyte) .
- the substrate is the analyte
- the dehydrogenase is the analyte
- the fibrils are drawn into an ECL instrument and the ECL of the fibrils is measured.
- ECL measurement is carried out in a buffer that does not contain appreciable concentrations of tripropylamine (because NAD(P) + /NAD(P)H are tripropylamine replacements in this invention) .
- the attractive features of this ECL-based biosensor are: the close proximity of NAD(P) + /NAD(P)H and Ru(bpy) 3 2+ on the same bifunctional group on the fibrils which enhances the efficiency of electron transfer in the electrochemical ECL mechanism (intramolecular electron transfer is more efficient than intermolecular electron transfer) ; the ECL active reagents, NAD(P) + /NAD(P)H and Ru(bpy) 3 2+ are both supported on fibrils which can be magnetically held on the ECL instrument electrode which will increase light emission; fibrils have extremely high surface areas which permit immobilization of a high density (per weight) of NAD(P) + /NAD(P)H and Ru(bpy) 3 2+ which will allow more light to be
- G6PDH glucose-6-Phosphate dehydrogenase
- Ru(bpy) 3 2+ analog being covalently attached to a bifunctional adduct were used to detect the enzyme glucose-6-phosphate dehydrogenase.
- ECL biosensor fibrils (860 ⁇ g/mL) were mixed with a neutral pH buffered solution containing approximately 50 ⁇ M glucose-6-phosphate.
- G6PDH a neutral pH buffered solution containing approximately 50 ⁇ M glucose-6-phosphate.
- G6PDH Into one tube was added G6PDH to a concentration of 3.6 ⁇ M.
- deionized water was Immediately the ECL of the fibrils was measured.
- Figure 9 shows that at time zero the ECL of the fibrils with (DH+) and without (DH-) G6PDH was a similar level.
- the background ECL resulting from the assay buffer (no fibrils) is also shown (A.B.). After 42 hours of incubation (rotation at room temperature) more fibrils were withdrawn and the ECL was measured again. As shown in Figure 9, the ECL of assay buffer (A.B.) and fibrils in the absence of G6PDH (DH-) was similar to the ECL seen at time zero. However, the ECL of the sample containing G6PDH (DH+) was substantially lower than at time zero. The results indicate that G6PDH activity could be detected using fibril supported ECL biosensors.
- An enzyme biosensor was prepared containing a dehydrogenase enzyme to which has been conjugated both an analog of a nicotinamide adenine dinucleotide (NAD + ) enzyme cofactor and an analog of ruthenium (II) tris- bipyridine (Ru(bpy) 3 2+ ) .
- the NAD + analog is tethered so that it can bind in the enzyme* s cofactor binding site and behave naturally when bound (i.e., it can be reduced by the enzyme by the normal chemical mechanism in the presence of the natural substrate of the enzyme) .
- the Ru(bpy) 3 2+ analog is tethered so that it can come into physical contact with the NAD + ( Figure 10) .
- NAD + and its reduced form, NADH promote Ru(bpy) 3 2+ electrochemiluminescence to different extents.
- NAD + , NADH, or some mixture of the two is present in a solution (F. Jameison et al., Analytical Chemistry, in press) .
- the biosensor uses the differences between the efficiencies of the ECL reactions of Ru(bpy) 3 2+ to detect the extent of reduction of NAD and hence the presence of the enzyme' s substrate.
- alcohol dehydrogenase catalyzes the reaction shown below; ethanol (reduced) + NAD + (oxidized) ⁇ acetaldehyde (oxidized) + NADH (reduced) .
- An alcohol dehydrogenase-based ECL biosensor can convert ethanol to acetaldehyde, concomitantly converting NAD + to NADH. Because the ECL properties of Ru(bpy) 3 2+ immobilized on the biosensor depend on whether NAD + or NADH is immobilized, the ECL of the enzyme biosensor can report the presence of ethanol.
- An attractive feature of the biosensor is that because during the ECL reaction the NADH form of the cofactor is re-oxidized to the NAD* form, one biosensor molecule can be used repeatedly to detect multiple molecules of analyte.
- the biosensor is based on a soluble enzyme (a dehydrogenase) and the analyte (ethanol for example) is also soluble, it would be beneficial to immobilize the biosensor so that it could be used repetitively to analyze different analyte-containing samples without being washed away with a spent analyte- containing solution.
- immobilization was carried out with an alcohol dehydrogenase (ADH) based ECL biosensor (shown schematically in Figure 10) .
- Figure 11 shows immobilization of the ADH-based biosensor on Dynal M450 beads (Lake Success, NY) (left) and immobilization on alkyl fibrils (right) .
- the alkyl fibrils were prepared by the reaction of oxidized fibrils (bearing COOH groups) with 1-aminooctane. In both cases (beads and fibrils) the enzyme biosensor was immobilized by noncovalent adsorption in buffered aqueous solution.
- Ethanol was detected using both bead- and fibril-immobilized ECL ADH-based biosensors.
- the amount of enzyme biosensor adsorbed to beads or fibrils was determined by measuring the amount of remaining (non- absorbed) protein in solution by the UV absorbance at 280 nm (the absorbance at 280 nm indicates the amount of protein in solution).
- the results showed that 0.308 mg of the ADH biosensor bound per mg of fibrils while 0.015 mg of the ADH biosensor bound per mg of beads.
- the absorptive capacity of fibrils exceed that of Dynal beads by 20.5 times.
- ECL sensing of ethanol was carried out by mixing the ADH biosensor adsorbed beads (0.50-1.25 mg) or fibrils (0.04-0.10 mg) with a solution containing 0.1 M sodium phosphate buffer (pH 7.2), 12 mM semicarbizide. Some samples also contained 0.5 mM of the analyte, ethanol.
- the solid supports coated with the biosensor were drawn into an IGEN Origen® ECL Analyzer (IGEN, Inc., Gaithersburg, MD) and ECL was. measured. Results of one such experiment are shown in Figure 12. With both beads and fibrils, the ECL signal of the enzyme biosensor decreased in the presence of ethanol.
- fibril surfaces can be biotinylated or both alkylated and biotinylated.
- the fibrils containing such modifications can then bind any streptavidin conjugated substances such as streptavidin beads and streptavidin enzymes.
- Fibrils offer great advantages as solid carriers because of their high surface area. Beads, which can be made strongly magnetic, are extremely useful in separation assays.
- the biotinylated fibrils described herein combine the advantages of both the fibrils and the beads.
- the biotinylated alkyl fibrils are an extension of the same concept but exhibit the additional protein adsorption property of alkyl fibrils.
- the streptavidin- and biotin-coated fibrils can be used in diagnostics and can be used as capture agents for electrochemiluminescence assays.
- a novel feature of this invention is the combination of two solid carriers on one fibril to create a bifunctional fibril. Moreover, the disclosed process increases the surface area for beads and magnifies fibril magnetization.
- Biotinylated fibrils were prepared by mixing 2.4 mg of amino fibrils prepared essentially as described in Preparation 0 and 9 mg of NHS ester long chain biotin in buffer 0.2 M NaHC0 3 at a pH of 8.15. The mixture was rotated at room temperature for four hours and washed with the same buffer twice.
- Biotinylated alkyl fibrils were prepared by a two step reaction. First, 4.25 mg of bifunctional fibrils (containing both amino and carboxyl) and 25 mg of NHS ester long chain biotin were mixed. The fibrils were washed and dried under vacuum.
- the second reaction was carried out by mixing 4 mg of biotinylated bifunctional fibrils with 11 mg of EDC (l-ethyl-3-(3-dimethylaminopropyl)carbodiimide) , 7.5 mg of DMAP (4-dimethylaminopyridine) and 10 ⁇ l of NH 2 (CH 2 ) 7 CH 3 in 0.5 ml of DMF. The mixture was stirred at room temperature overnight. The final biotinylated alkyl fibrils were washed by CH 2 C1 2 , MeOH, and dH 2 0.
- Biotinylated fibrils can be used in ECL assays involving formats that require streptavidin-biotin or avidin-biotin interactions. Biotinylated fibrils could for example be further derivatized with streptavidin. Biotin covalently linked to fibrils (see Example 13) could form strong non-covalent binding interactions with streptavidin. Because streptavidin is a tetrameric protein with four equivalent binding sites, streptavidin bound to biotinylated fibrils would almost certainly have unoccupied binding sites to which additional biotinylated reagents could bind. Thus, biotinylated fibrils would be converted to streptavidin-coated fibrils.
- FBS fibril-biotin-streptavidin
- a biotinylated anti-analyte antibody could be captured on the FBS support (either before or after the antibody has complexed to an analyte) .
- Assays using biotinylated anti-analyte antibodies are well established. Such assays include competitive assays where the analyte of interest competes with an introduced Ru(bpy) 3 2+ -labeled analyte for binding to the anti-analyte antibody.
- Free (unbound) analyte and free (unbound) Ru(bpy) 3 2+ -labeled analyte can be washed from the fibril immobilized antibody.
- the washing step depends on the fibrils being physically separated from the solution phase by common practices involving centrifugation, filtration, or by attraction to a magnet.
- Sandwich immunoassays are well known in the field of diagnostics in general and in ECL detection in specific. Such assays involve an analyte being bound simultaneously by two antibodies; a first "primary” antibody which is captured on a solid surface by for example being labeled with biotin, and a "secondary” antibody which is not captured by a solid surface but is labeled with a reporter group, such as Ru(bpy) 3 2+ in ECL applications.
- a sandwich assay could be carried out using fibrils as a solid capture support whereby the fibrils are captured as described in the previous paragraph.
- the fibril would have covalently linked to it biotin, which would be bound to streptavidin, which would in turn be bound to a biotinylated primary antibody, which would be bound to analyte (if present), which would be bound to a Ru(bpy) 3 2+ -labeled secondary antibody.
- DNA probe assays could be carried out using FBS supports. Biotinylated single stranded DNA can be bound to FBS supports and competitive hybridization can occur between complementary single stranded analyte DNA molecules and complementary Ru(bpy) 3 2+ -labeled oligonucleotides.
- biotinylated fibrils can be used in immunoassays and DNA probe assays.
- bifunctional fibrils can be modified by covalent attachment of biotin to one type of functional group and alkyl chains to the other type of functional group.
- the resultant alkylated, biotinylated fibrils can be used both in specific association with streptavidin or avidin (via biotin) and also for adsorption of proteins (via the alkyl chains) .
- Alkyl fibrils could be used in conjunction with other solid supports, such as streptavidin-coated magnetic beads, including Dynal magnetic beads.
- streptavidin-coated magnetic beads including Dynal magnetic beads.
- One advantage of fibrils over such beads is that they have a much higher surface area (per unit weight). Thus, if fibrils could be attached to the outside surface of the magnetic beads, this would dramatically improve the surface area and hence the binding capacity of the beads.
- alkylated, biotinylated fibrils could be mixed with streptavidin-coated beads resultir»9 in high affinity streptavidin(bead)-biotin(fibril) interactions and hence fibril-coated beads with an extremely high surface area.
- fibril-coated beads could be further derivatized with adsorbed proteins including streptavidin and antibodies.
- streptavidin or antibody coated fibrils can be used in immunoassays and DNA probe assays.
- fibril- coated beads could improve the properties of the beads by dramatically increasing their surface area such that fewer beads would be required in a given assay to give the same result.
- Fibrils may have magnetic properties.
- the extent to which fibrils can be made magnetic or non ⁇ magnetic is controlled by the amount of catalyst that is in the fibril as a result of the fibril production process.
- Such processes are disclosed in U.S. Patents 4,663,230, 5,165,909 and 5,171,560.
- Stock dispersions of chlorate oxidized fibrils, fibrils modified with PEG using benzoyl peroxide and fibrils modified with PEG by NHS ester coupling were prepared at l.Omg/ml in 50mM potassium phosphate buffer, pH 7.0 with sonication. 2 mis of 10-fold serial dilutions of each were placed in each of 5 polypropylene tubes. 50 ⁇ l of a stock solution of Ru(Bpy) 3 (approx. 10 ⁇ M) in the same buffer was added to each tube and to 3 buffer blanks. Three buffer tubes without Ru(Bpy) 3 were also prepared. All tubes were mixed on a vortex mixer and allowed to incubate overnight.
- Ru(Bpy) 3 remained in the supernatant at fibril levels up to 0.1 mg/ml. There was 20-30% decrease in the Ru(Bpy) 3 in the supernatant at 1.0 mgs/ml of these fibrils. In contrast, for the chlorate oxidized fibrils, there was almost no Ru(Bpy) 3 remaining in the supernatant at 1.0 mgs/ml and 20-30% decrease in the Ru(Bpy) 3 in the supernatant at 0.1 mg/ml of these fibrils without the PEG modification.
- Reddy EP Reynolds RK
- Santo E Barbacid M.
- a point mutation is responsible for the acquisition of the transforming properties by the T24 humanbladder carcinoma oncogene. Nature 1982; 300:149-52.
Abstract
Description
Claims
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP53198997A JP3791930B2 (en) | 1996-03-06 | 1997-03-05 | Graphite nanotubes in luminescence assays |
CA2248893A CA2248893C (en) | 1996-03-06 | 1997-03-05 | Graphitic nanotubes in luminescence assays |
DE69737765T DE69737765T2 (en) | 1996-03-06 | 1997-03-05 | GRAPHITE NUTS IN LUMINESCENT ASSAYS |
AU20737/97A AU724509B2 (en) | 1996-03-06 | 1997-03-05 | Graphitic nanotubes in luminescence assays |
EP97908967A EP0885393B1 (en) | 1996-03-06 | 1997-03-05 | Graphitic nanotubes in luminescence assays |
IL12598597A IL125985A (en) | 1996-03-06 | 1997-03-05 | Graphitic nanotubes in luminescence assays |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/611,347 | 1996-03-06 | ||
US08/611,347 US5866434A (en) | 1994-12-08 | 1996-03-06 | Graphitic nanotubes in luminescence assays |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1997033176A1 true WO1997033176A1 (en) | 1997-09-12 |
Family
ID=24448667
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1997/003653 WO1997033176A1 (en) | 1996-03-06 | 1997-03-05 | Graphitic nanotubes in luminescence assays |
Country Status (13)
Country | Link |
---|---|
US (4) | US5866434A (en) |
EP (1) | EP0885393B1 (en) |
JP (1) | JP3791930B2 (en) |
KR (1) | KR100463002B1 (en) |
CN (1) | CN1174248C (en) |
AT (1) | ATE363660T1 (en) |
AU (1) | AU724509B2 (en) |
CA (1) | CA2248893C (en) |
DE (1) | DE69737765T2 (en) |
IL (1) | IL125985A (en) |
RU (1) | RU2189043C2 (en) |
WO (1) | WO1997033176A1 (en) |
ZA (1) | ZA971915B (en) |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0944820A1 (en) * | 1996-09-17 | 1999-09-29 | Meso Scale Technologies, LLC. | Multi-array, multi-specific electrochemiluminescent testing |
EP1018015A1 (en) * | 1997-09-18 | 2000-07-12 | Meso Scale Technologies LLC | Assay sonication apparatus and methodology |
US6214552B1 (en) | 1998-09-17 | 2001-04-10 | Igen International, Inc. | Assays for measuring nucleic acid damaging activities |
US6312896B1 (en) | 1998-09-17 | 2001-11-06 | Igen Inaternational, Inc. | Assays for measuring nucleic acid binding proteins and enzyme activities |
DE10035365A1 (en) * | 2000-07-20 | 2002-02-07 | Infineon Technologies Ag | Production of a photosensitive nanotube used in the production of nano switching circuits, comprises deriving the tube, and coupling a dye excited by light on the tube via the chemically reactive groups |
CN1111573C (en) * | 1999-05-12 | 2003-06-18 | 中国科学院感光化学研究所 | Pneumatic pressure-sensitive lacquer and its preparing process |
EP1552011A2 (en) * | 2002-07-23 | 2005-07-13 | THE TEXAS A & M UNIVERSITY SYSTEMS | Photonic signal reporting of electrochemical events |
JP2010249826A (en) * | 1997-10-06 | 2010-11-04 | Trustees Of Tufts College | Method of amplifying signal generated from enzyme reaction |
US8426217B2 (en) | 1997-10-06 | 2013-04-23 | Trustees Of Tufts College | Self-encoding sensor with microspheres |
US9414777B2 (en) | 2004-07-13 | 2016-08-16 | Dexcom, Inc. | Transcutaneous analyte sensor |
US9986942B2 (en) | 2004-07-13 | 2018-06-05 | Dexcom, Inc. | Analyte sensor |
WO2018229775A1 (en) * | 2017-06-14 | 2018-12-20 | Sensogenic Ltd | Sensing system and method for detection of cbm containing analytes using their binding to cellulosic substrates |
US10610136B2 (en) | 2005-03-10 | 2020-04-07 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10813577B2 (en) | 2005-06-21 | 2020-10-27 | Dexcom, Inc. | Analyte sensor |
US11099180B2 (en) | 2017-02-02 | 2021-08-24 | Roche Diagnostics Operations, Inc. | Immunoassay using at least two pegylated analyte-specific binding agents |
US11391733B2 (en) | 2015-08-20 | 2022-07-19 | Roche Diagnostics Operations, Inc. | Particle-based immunoassay using a pegylated analyte-specific binding agent |
US11971407B2 (en) | 2016-03-07 | 2024-04-30 | Roche Diagnostics Operations, Inc. | Detection of anti-p53 antibodies |
Families Citing this family (276)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5866434A (en) * | 1994-12-08 | 1999-02-02 | Meso Scale Technology | Graphitic nanotubes in luminescence assays |
US6673533B1 (en) | 1995-03-10 | 2004-01-06 | Meso Scale Technologies, Llc. | Multi-array multi-specific electrochemiluminescence testing |
US20020056686A1 (en) * | 1996-06-14 | 2002-05-16 | Agathagelos Kyrlidis | Chromatography and other adsorptions using modified carbon adsorbents |
US6479030B1 (en) * | 1997-09-16 | 2002-11-12 | Inorganic Specialists, Inc. | Carbon electrode material |
EP0949199B1 (en) * | 1998-04-09 | 2003-05-21 | Horcom Limited | Composition including nanotubes and an organic compound |
AU3529299A (en) * | 1998-05-07 | 1999-11-23 | Centre National De La Recherche Scientifique-Cnrs | Method for immobilising and/or crystallising biological macromolecules on carbonnanotubes and uses |
US6159742A (en) * | 1998-06-05 | 2000-12-12 | President And Fellows Of Harvard College | Nanometer-scale microscopy probes |
US6426134B1 (en) * | 1998-06-30 | 2002-07-30 | E. I. Du Pont De Nemours And Company | Single-wall carbon nanotube-polymer composites |
US7416699B2 (en) * | 1998-08-14 | 2008-08-26 | The Board Of Trustees Of The Leland Stanford Junior University | Carbon nanotube devices |
US6346189B1 (en) * | 1998-08-14 | 2002-02-12 | The Board Of Trustees Of The Leland Stanford Junior University | Carbon nanotube structures made using catalyst islands |
US6936565B2 (en) | 1999-01-12 | 2005-08-30 | Hyperion Catalysis International, Inc. | Modified carbide and oxycarbide containing catalysts and methods of making and using thereof |
EP1152827A4 (en) * | 1999-01-12 | 2002-11-06 | Hyperion Catalysis Int | Carbide and oxycarbide based compositions and nanorods |
EP1920837A3 (en) * | 1999-01-12 | 2008-11-19 | Hyperion Catalysis International, Inc. | Carbide and oxycarbide based compositions and nanorods |
US6514897B1 (en) | 1999-01-12 | 2003-02-04 | Hyperion Catalysis International, Inc. | Carbide and oxycarbide based compositions, rigid porous structures including the same, methods of making and using the same |
US6809229B2 (en) * | 1999-01-12 | 2004-10-26 | Hyperion Catalysis International, Inc. | Method of using carbide and/or oxycarbide containing compositions |
US20030073250A1 (en) * | 1999-05-21 | 2003-04-17 | Eric Henderson | Method and apparatus for solid state molecular analysis |
US6573369B2 (en) * | 1999-05-21 | 2003-06-03 | Bioforce Nanosciences, Inc. | Method and apparatus for solid state molecular analysis |
US20020042081A1 (en) * | 2000-10-10 | 2002-04-11 | Eric Henderson | Evaluating binding affinities by force stratification and force panning |
US20030186311A1 (en) * | 1999-05-21 | 2003-10-02 | Bioforce Nanosciences, Inc. | Parallel analysis of molecular interactions |
EP1226294B1 (en) * | 1999-07-21 | 2011-06-29 | Hyperion Catalysis International, Inc. | Methods of oxidizing multiwalled carbon nanotubes |
US6437329B1 (en) | 1999-10-27 | 2002-08-20 | Advanced Micro Devices, Inc. | Use of carbon nanotubes as chemical sensors by incorporation of fluorescent molecules within the tube |
CA2390261C (en) * | 1999-11-08 | 2014-04-22 | University Of Florida Research Foundation, Inc. | Marker detection method and apparatus to monitor drug compliance |
US20020177232A1 (en) * | 2001-05-23 | 2002-11-28 | Melker Richard J. | Method and apparatus for detecting illicit substances |
US20050037374A1 (en) * | 1999-11-08 | 2005-02-17 | Melker Richard J. | Combined nanotechnology and sensor technologies for simultaneous diagnosis and treatment |
US20050233459A1 (en) * | 2003-11-26 | 2005-10-20 | Melker Richard J | Marker detection method and apparatus to monitor drug compliance |
ATE402407T1 (en) * | 1999-12-15 | 2008-08-15 | Univ Leland Stanford Junior | CARBON NANOTUBE DEVICE |
US20030013094A1 (en) * | 2001-02-17 | 2003-01-16 | Weiner Michael L. | Hybrid nucleic acid assembly |
US20040146918A1 (en) * | 2000-02-18 | 2004-07-29 | Weiner Michael L. | Hybrid nucleic acid assembly |
US6897015B2 (en) * | 2000-03-07 | 2005-05-24 | Bioforce Nanosciences, Inc. | Device and method of use for detection and characterization of pathogens and biological materials |
US6455847B1 (en) | 2000-04-26 | 2002-09-24 | Advanced Micro Devices, Inc. | Carbon nanotube probes in atomic force microscope to detect partially open/closed contacts |
US6730284B2 (en) | 2000-06-16 | 2004-05-04 | Honda Giken Kogyo Kabushiki Kaisha | Method for producing carbonaceous articles |
US7199015B2 (en) * | 2000-08-08 | 2007-04-03 | Translucent Photonics, Inc. | Rare earth-oxides, rare earth-nitrides, rare earth-phosphides and ternary alloys with silicon |
US6451175B1 (en) | 2000-08-15 | 2002-09-17 | Wisconsin Alumni Research Foundation | Method and apparatus for carbon nanotube production |
ATE402760T1 (en) * | 2000-08-15 | 2008-08-15 | Bioforce Nanosciences Inc | DEVICE FOR FORMING NANOMOLECULAR NETWORKS |
US20060175601A1 (en) * | 2000-08-22 | 2006-08-10 | President And Fellows Of Harvard College | Nanoscale wires and related devices |
KR100984585B1 (en) * | 2000-08-22 | 2010-09-30 | 프레지던트 앤드 펠로우즈 오브 하버드 칼리지 | Nanosensors |
US7301199B2 (en) * | 2000-08-22 | 2007-11-27 | President And Fellows Of Harvard College | Nanoscale wires and related devices |
KR20030059187A (en) * | 2000-10-10 | 2003-07-07 | 바이오포스 나노사이언스, 인크. | Nanoscale sensor |
IL138988A (en) * | 2000-10-12 | 2005-09-25 | Yissum Res Dev Co | Dendritically amplified detection method |
US6981947B2 (en) * | 2002-01-22 | 2006-01-03 | University Of Florida Research Foundation, Inc. | Method and apparatus for monitoring respiratory gases during anesthesia |
US7104963B2 (en) * | 2002-01-22 | 2006-09-12 | University Of Florida Research Foundation, Inc. | Method and apparatus for monitoring intravenous (IV) drug concentration using exhaled breath |
US20050054942A1 (en) * | 2002-01-22 | 2005-03-10 | Melker Richard J. | System and method for therapeutic drug monitoring |
KR20090049095A (en) * | 2000-12-11 | 2009-05-15 | 프레지던트 앤드 펠로우즈 오브 하버드 칼리지 | Nanosensors |
US6958216B2 (en) * | 2001-01-10 | 2005-10-25 | The Trustees Of Boston College | DNA-bridged carbon nanotube arrays |
US20020093006A1 (en) * | 2001-01-16 | 2002-07-18 | Vardeny Z. Valy | Performance of organic light-emitting devices using spin-dependent processes |
US7052668B2 (en) * | 2001-01-31 | 2006-05-30 | William Marsh Rice University | Process utilizing seeds for making single-wall carbon nanotubes |
US6913789B2 (en) * | 2001-01-31 | 2005-07-05 | William Marsh Rice University | Process utilizing pre-formed cluster catalysts for making single-wall carbon nanotubes |
US6716596B2 (en) * | 2001-03-12 | 2004-04-06 | The Regents Of The University Of California | Agents for replacement of NAD+/NADH system in enzymatic reactions |
US6750438B2 (en) | 2001-03-14 | 2004-06-15 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Single-element electron-transfer optical detector system |
US6765190B2 (en) | 2001-03-14 | 2004-07-20 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Multi-element electron-transfer optical detector system |
JP3578098B2 (en) | 2001-03-16 | 2004-10-20 | 富士ゼロックス株式会社 | Manufacturing method of electrical connector, electrical connector, and electrical wiring method |
US8029734B2 (en) * | 2001-03-29 | 2011-10-04 | The Board Of Trustees Of The Leland Stanford Junior University | Noncovalent sidewall functionalization of carbon nanotubes |
US6740403B2 (en) | 2001-04-02 | 2004-05-25 | Toyo Tanso Co., Ltd. | Graphitic polyhederal crystals in the form of nanotubes, whiskers and nanorods, methods for their production and uses thereof |
US7459312B2 (en) * | 2001-04-18 | 2008-12-02 | The Board Of Trustees Of The Leland Stanford Junior University | Photodesorption in carbon nanotubes |
WO2002088025A1 (en) * | 2001-04-26 | 2002-11-07 | New York University | Method for dissolving carbon nanotubes |
US7132275B2 (en) * | 2001-05-14 | 2006-11-07 | The John Hopkins University | Multifunctional magnetic nanowires |
GB0111875D0 (en) * | 2001-05-15 | 2001-07-04 | Univ Cambridge Tech | Synthesis of nanoscaled carbon materials |
US6723299B1 (en) * | 2001-05-17 | 2004-04-20 | Zyvex Corporation | System and method for manipulating nanotubes |
US7052854B2 (en) * | 2001-05-23 | 2006-05-30 | University Of Florida Research Foundation, Inc. | Application of nanotechnology and sensor technologies for ex-vivo diagnostics |
EP1393069A1 (en) | 2001-05-24 | 2004-03-03 | The University Of Florida | Method and apparatus for detecting environmental smoke exposure |
US20030148380A1 (en) * | 2001-06-05 | 2003-08-07 | Belcher Angela M. | Molecular recognition of materials |
US20050164515A9 (en) * | 2001-06-05 | 2005-07-28 | Belcher Angela M. | Biological control of nanoparticle nucleation, shape and crystal phase |
US20030113714A1 (en) * | 2001-09-28 | 2003-06-19 | Belcher Angela M. | Biological control of nanoparticles |
WO2003084865A2 (en) * | 2001-06-14 | 2003-10-16 | Hyperion Catalysis International, Inc. | Field emission devices using modified carbon nanotubes |
CA2451789C (en) | 2001-06-29 | 2012-03-27 | Meso Scale Technologies, Llc. | Assay plates, reader systems and methods for luminescence test measurements |
US6896864B2 (en) * | 2001-07-10 | 2005-05-24 | Battelle Memorial Institute | Spatial localization of dispersed single walled carbon nanotubes into useful structures |
AU2002354929A1 (en) * | 2001-07-16 | 2003-03-03 | The Trustees Of Columbia University In The City Of New York | Antibodies specific for nanotubes and related methods and compositions |
AU2002329606A1 (en) * | 2001-07-17 | 2003-03-03 | Bioforce Nanosciences, Inc. | Combined molecular blinding detection through force microscopy and mass spectrometry |
US6705792B2 (en) | 2002-06-25 | 2004-03-16 | Watch Hill Harbor Technologies | Cleaning attachment for converting a cleaning implement to a mop |
AU2002365119A1 (en) * | 2001-07-30 | 2003-09-04 | Meso Scale Technologies, Llc. | Assay electrodes having immobilized lipid/protein layers and methods of making and using the same |
KR100455284B1 (en) * | 2001-08-14 | 2004-11-12 | 삼성전자주식회사 | High-throughput sensor for detecting biomolecules using carbon nanotubes |
WO2003022028A2 (en) | 2001-09-10 | 2003-03-20 | Meso Scale Technologies, Llc | Methods, reagents, kits and apparatus for protein function analysis |
US7042488B2 (en) | 2001-09-27 | 2006-05-09 | Fujinon Corporation | Electronic endoscope for highlighting blood vessel |
US7183228B1 (en) | 2001-11-01 | 2007-02-27 | The Board Of Trustees Of The Leland Stanford Junior University | Carbon nanotube growth |
US7318908B1 (en) | 2001-11-01 | 2008-01-15 | The Board Of Trustees Of The Leland Stanford Junior University | Integrated nanotube sensor |
US6821730B2 (en) * | 2001-11-09 | 2004-11-23 | Intel Corporation | Carbon nanotube molecular labels |
US7022541B1 (en) | 2001-11-19 | 2006-04-04 | The Board Of Trustees Of The Leland Stanford Junior University | Patterned growth of single-walled carbon nanotubes from elevated wafer structures |
KR100408871B1 (en) * | 2001-12-20 | 2003-12-11 | 삼성전자주식회사 | Method of separation or filtration by carbon nanotube in biochip |
US20030119203A1 (en) * | 2001-12-24 | 2003-06-26 | Kimberly-Clark Worldwide, Inc. | Lateral flow assay devices and methods for conducting assays |
US8367013B2 (en) * | 2001-12-24 | 2013-02-05 | Kimberly-Clark Worldwide, Inc. | Reading device, method, and system for conducting lateral flow assays |
US7338648B2 (en) * | 2001-12-28 | 2008-03-04 | The Penn State Research Foundation | Method for low temperature synthesis of single wall carbon nanotubes |
US20070178477A1 (en) * | 2002-01-16 | 2007-08-02 | Nanomix, Inc. | Nanotube sensor devices for DNA detection |
US8154093B2 (en) | 2002-01-16 | 2012-04-10 | Nanomix, Inc. | Nano-electronic sensors for chemical and biological analytes, including capacitance and bio-membrane devices |
US20070167853A1 (en) * | 2002-01-22 | 2007-07-19 | Melker Richard J | System and method for monitoring health using exhaled breath |
JP4208722B2 (en) * | 2002-03-04 | 2009-01-14 | ウィリアム・マーシュ・ライス・ユニバーシティ | Method for separating single-walled carbon nanotubes |
EP1461390A1 (en) * | 2002-04-01 | 2004-09-29 | Carbon Nanotechnologies, Inc. | Composite of single-wall carbon nanotubes and aromatic polyamide and process for making the same |
US6831017B1 (en) | 2002-04-05 | 2004-12-14 | Integrated Nanosystems, Inc. | Catalyst patterning for nanowire devices |
AU2003226428A1 (en) * | 2002-04-18 | 2003-11-03 | Northwestern University | Encapsulation of nanotubes via self-assembled nanostructures |
US6806223B2 (en) * | 2002-04-19 | 2004-10-19 | Central Michigan University Board Of Trustees | Single oxygen catalysts including condensed carbon molecules |
US7341972B2 (en) * | 2002-04-19 | 2008-03-11 | Jensen Anton W | Singlet oxygen catalysts including condensed carbon molecules |
US6905667B1 (en) | 2002-05-02 | 2005-06-14 | Zyvex Corporation | Polymer and method for using the polymer for noncovalently functionalizing nanotubes |
US20040034177A1 (en) | 2002-05-02 | 2004-02-19 | Jian Chen | Polymer and method for using the polymer for solubilizing nanotubes |
US7771922B2 (en) * | 2002-05-03 | 2010-08-10 | Kimberly-Clark Worldwide, Inc. | Biomolecule diagnostic device |
US7223534B2 (en) * | 2002-05-03 | 2007-05-29 | Kimberly-Clark Worldwide, Inc. | Diffraction-based diagnostic devices |
US7223368B2 (en) * | 2002-05-03 | 2007-05-29 | Kimberly-Clark Worldwide, Inc. | Diffraction-based diagnostic devices |
US7214530B2 (en) * | 2002-05-03 | 2007-05-08 | Kimberly-Clark Worldwide, Inc. | Biomolecule diagnostic devices and method for producing biomolecule diagnostic devices |
AU2003267892A1 (en) * | 2002-05-08 | 2003-11-11 | The Board Of Trustees Of The Leland Stanford Junior University | Nanotube mat with an array of conduits |
US20050239193A1 (en) * | 2002-05-30 | 2005-10-27 | Bioforce Nanosciences, Inc. | Device and method of use for detection and characterization of microorganisms and microparticles |
US7304128B2 (en) * | 2002-06-04 | 2007-12-04 | E.I. Du Pont De Nemours And Company | Carbon nanotube binding peptides |
US7948041B2 (en) | 2005-05-19 | 2011-05-24 | Nanomix, Inc. | Sensor having a thin-film inhibition layer |
US7517656B2 (en) * | 2002-07-30 | 2009-04-14 | Trex Enterprises Corp. | Optical sensor and methods for measuring molecular binding interactions |
US7013708B1 (en) | 2002-07-11 | 2006-03-21 | The Board Of Trustees Of The Leland Stanford Junior University | Carbon nanotube sensors |
WO2004010552A1 (en) | 2002-07-19 | 2004-01-29 | President And Fellows Of Harvard College | Nanoscale coherent optical components |
CN100541700C (en) * | 2002-07-30 | 2009-09-16 | 学校法人浦项工科大学校 | Use the electric field emission with audion and the manufacture method thereof of anode oxidation process manufacturing |
US7432105B2 (en) * | 2002-08-27 | 2008-10-07 | Kimberly-Clark Worldwide, Inc. | Self-calibration system for a magnetic binding assay |
US7285424B2 (en) | 2002-08-27 | 2007-10-23 | Kimberly-Clark Worldwide, Inc. | Membrane-based assay devices |
AU2002951274A0 (en) * | 2002-08-30 | 2002-09-19 | Commonwealth Scientific And Industrial Research Organisation | Methods for the chemical and physical modification of nanotubes, methods for linking the nanotubes, methods for the directed positioning of nanotubes, and uses thereof |
US20060160134A1 (en) * | 2002-10-21 | 2006-07-20 | Melker Richard J | Novel application of biosensors for diagnosis and treatment of disease |
US7498423B2 (en) * | 2002-11-21 | 2009-03-03 | E.I. Du Pont De Nemours & Company | Carbon nanotube-nucleic acid complexes |
US7781172B2 (en) * | 2003-11-21 | 2010-08-24 | Kimberly-Clark Worldwide, Inc. | Method for extending the dynamic detection range of assay devices |
US20040106190A1 (en) * | 2002-12-03 | 2004-06-03 | Kimberly-Clark Worldwide, Inc. | Flow-through assay devices |
US20060257657A1 (en) * | 2002-12-10 | 2006-11-16 | Seamus Curran | Nanotube based non-linear optics and methods of making same |
US7247500B2 (en) * | 2002-12-19 | 2007-07-24 | Kimberly-Clark Worldwide, Inc. | Reduction of the hook effect in membrane-based assay devices |
WO2004060044A2 (en) * | 2003-01-02 | 2004-07-22 | Bioforce Nanosciences, Inc. | Method and apparatus for molecular analysis in small sample volumes |
CA2516820A1 (en) * | 2003-02-07 | 2004-11-18 | Wisconsin Alumni Research Foundation | Nanocylinder-modified surfaces |
KR100591526B1 (en) * | 2003-02-22 | 2006-06-20 | 광주과학기술원 | Preparation of novel carbon nanotubes-nucleic acids conjugates |
US20040186459A1 (en) * | 2003-03-20 | 2004-09-23 | Michael Shur | Fluid delivery to cells and sensing properties of cells using nanotubes |
US7851209B2 (en) | 2003-04-03 | 2010-12-14 | Kimberly-Clark Worldwide, Inc. | Reduction of the hook effect in assay devices |
US20040197819A1 (en) * | 2003-04-03 | 2004-10-07 | Kimberly-Clark Worldwide, Inc. | Assay devices that utilize hollow particles |
US7972616B2 (en) * | 2003-04-17 | 2011-07-05 | Nanosys, Inc. | Medical device applications of nanostructured surfaces |
US20050038498A1 (en) * | 2003-04-17 | 2005-02-17 | Nanosys, Inc. | Medical device applications of nanostructured surfaces |
US7579077B2 (en) * | 2003-05-05 | 2009-08-25 | Nanosys, Inc. | Nanofiber surfaces for use in enhanced surface area applications |
US7803574B2 (en) * | 2003-05-05 | 2010-09-28 | Nanosys, Inc. | Medical device applications of nanostructured surfaces |
TWI427709B (en) * | 2003-05-05 | 2014-02-21 | Nanosys Inc | Nanofiber surfaces for use in enhanced surface area applications |
GB2421506B (en) * | 2003-05-22 | 2008-07-09 | Zyvex Corp | Nanocomposites and methods thereto |
KR100525764B1 (en) * | 2003-06-13 | 2005-11-04 | 한국과학기술원 | Biosensor using the conductive carbon nanotubes and method thereof |
US7670831B2 (en) * | 2003-06-13 | 2010-03-02 | Korea Advanced Institute Of Science And Technology | Conductive carbon nanotubes dotted with metal and method for fabricating a biosensor using the same |
US7169329B2 (en) * | 2003-07-07 | 2007-01-30 | The Research Foundation Of State University Of New York | Carbon nanotube adducts and methods of making the same |
WO2005059506A2 (en) * | 2003-07-08 | 2005-06-30 | Johns Hopkins University | Method and magnetic microarray system for trapping and manipulating cells |
JP2005041835A (en) * | 2003-07-24 | 2005-02-17 | Fuji Xerox Co Ltd | Carbon nanotube structure, method for producing the same, carbon nanotube transfer and solution |
JP4927319B2 (en) * | 2003-07-24 | 2012-05-09 | 韓国科学技術園 | Biochip manufacturing method using high-density carbon nanotube film or pattern |
JP4380282B2 (en) * | 2003-09-26 | 2009-12-09 | 富士ゼロックス株式会社 | Method for producing carbon nanotube composite structure |
US7399400B2 (en) * | 2003-09-30 | 2008-07-15 | Nano-Proprietary, Inc. | Nanobiosensor and carbon nanotube thin film transistors |
US20090068461A1 (en) * | 2003-10-16 | 2009-03-12 | The University Of Akron | Carbon nanotubes on carbon nanofiber substrate |
US7981362B2 (en) | 2003-11-04 | 2011-07-19 | Meso Scale Technologies, Llc | Modular assay plates, reader systems and methods for test measurements |
US7943395B2 (en) * | 2003-11-21 | 2011-05-17 | Kimberly-Clark Worldwide, Inc. | Extension of the dynamic detection range of assay devices |
US20050112703A1 (en) | 2003-11-21 | 2005-05-26 | Kimberly-Clark Worldwide, Inc. | Membrane-based lateral flow assay devices that utilize phosphorescent detection |
US7713748B2 (en) * | 2003-11-21 | 2010-05-11 | Kimberly-Clark Worldwide, Inc. | Method of reducing the sensitivity of assay devices |
KR100557338B1 (en) * | 2003-11-27 | 2006-03-06 | 한국과학기술원 | Method for Producing a Carbon Nanotubes Wrapped with Self-Assembly Materials |
JP4238715B2 (en) * | 2003-12-15 | 2009-03-18 | 富士ゼロックス株式会社 | Electrochemical measurement electrode |
US20050244811A1 (en) | 2003-12-15 | 2005-11-03 | Nano-Proprietary, Inc. | Matrix array nanobiosensor |
US7943089B2 (en) * | 2003-12-19 | 2011-05-17 | Kimberly-Clark Worldwide, Inc. | Laminated assay devices |
US20050136550A1 (en) * | 2003-12-19 | 2005-06-23 | Kimberly-Clark Worldwide, Inc. | Flow control of electrochemical-based assay devices |
US20090227107A9 (en) * | 2004-02-13 | 2009-09-10 | President And Fellows Of Havard College | Nanostructures Containing Metal Semiconductor Compounds |
US7429371B2 (en) * | 2004-03-02 | 2008-09-30 | E. I. Du Pont De Nemours And Company | Reversible oxidation of carbon nanotubes |
KR100533316B1 (en) * | 2004-03-27 | 2005-12-02 | 한국과학기술원 | Method for Manufacturing a Carbon Nanotube Multilayer Pattern Using Photolithography and Dry Etching |
CN1954028A (en) * | 2004-04-13 | 2007-04-25 | 塞威公司 | Methods for the synthesis of modular poly(phenyleneethynlenes) and fine tuning the electronic properties thereof for the functionalization of nanomaterials |
US7815854B2 (en) * | 2004-04-30 | 2010-10-19 | Kimberly-Clark Worldwide, Inc. | Electroluminescent illumination source for optical detection systems |
US20050244953A1 (en) * | 2004-04-30 | 2005-11-03 | Kimberly-Clark Worldwide, Inc. | Techniques for controlling the optical properties of assay devices |
US20060019265A1 (en) * | 2004-04-30 | 2006-01-26 | Kimberly-Clark Worldwide, Inc. | Transmission-based luminescent detection systems |
US7796266B2 (en) * | 2004-04-30 | 2010-09-14 | Kimberly-Clark Worldwide, Inc. | Optical detection system using electromagnetic radiation to detect presence or quantity of analyte |
WO2006107312A1 (en) * | 2004-06-15 | 2006-10-12 | President And Fellows Of Harvard College | Nanosensors |
JP2006008861A (en) * | 2004-06-25 | 2006-01-12 | Fuji Xerox Co Ltd | Coating material for electric part and method for forming coating film |
US7906276B2 (en) * | 2004-06-30 | 2011-03-15 | Kimberly-Clark Worldwide, Inc. | Enzymatic detection techniques |
US7094528B2 (en) * | 2004-06-30 | 2006-08-22 | Kimberly-Clark Worldwide, Inc. | Magnetic enzyme detection techniques |
US7521226B2 (en) * | 2004-06-30 | 2009-04-21 | Kimberly-Clark Worldwide, Inc. | One-step enzymatic and amine detection technique |
WO2007013872A2 (en) * | 2004-07-22 | 2007-02-01 | The Board Of Trustees Of The University Of Illinois | Sensors employing single-walled carbon nanotubes |
US7296576B2 (en) * | 2004-08-18 | 2007-11-20 | Zyvex Performance Materials, Llc | Polymers for enhanced solubility of nanomaterials, compositions and methods therefor |
US9494581B2 (en) | 2004-08-24 | 2016-11-15 | University Of Wyoming | System and method for Raman spectroscopy assay using paramagnetic particles |
US20060062734A1 (en) * | 2004-09-20 | 2006-03-23 | Melker Richard J | Methods and systems for preventing diversion of prescription drugs |
US20060099721A1 (en) * | 2004-10-06 | 2006-05-11 | Feng Chen | Radioimmunoassay using nanoparticle-antibody conjugates |
WO2007040559A2 (en) * | 2004-11-17 | 2007-04-12 | Bioveris | Electrochemiluminescent assay |
DE502005003509D1 (en) * | 2004-11-19 | 2008-05-08 | Ebm Papst St Georgen Gmbh & Co | ARRANGEMENT WITH ONE FAN AND ONE PUMP |
US7348592B2 (en) | 2004-11-29 | 2008-03-25 | The United States Of America As Represented By The Secretary Of The Navy | Carbon nanotube apparatus and method of carbon nanotube modification |
JP2008523590A (en) * | 2004-12-06 | 2008-07-03 | プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ | Nanoscale wire-based data storage device |
TWI406940B (en) * | 2004-12-14 | 2013-09-01 | Nano Proprietary Inc | Matrix array nanobiosensor |
US20070121113A1 (en) * | 2004-12-22 | 2007-05-31 | Cohen David S | Transmission-based optical detection systems |
JP4452827B2 (en) * | 2004-12-28 | 2010-04-21 | 独立行政法人産業技術総合研究所 | Scanning magnetic force microscope probe, manufacturing method thereof, and ferromagnetic alloy film forming method for carbon nanotube |
KR100667307B1 (en) | 2005-01-11 | 2007-01-12 | 삼성전자주식회사 | Bio-bonding detection apparatus using RF wireless enery transmission and method thereof |
US7939342B2 (en) | 2005-03-30 | 2011-05-10 | Kimberly-Clark Worldwide, Inc. | Diagnostic test kits employing an internal calibration system |
US20070020650A1 (en) * | 2005-04-01 | 2007-01-25 | Avak Kahvejian | Methods for detecting proteins |
US20060246576A1 (en) * | 2005-04-06 | 2006-11-02 | Affymetrix, Inc. | Fluidic system and method for processing biological microarrays in personal instrumentation |
WO2006116683A1 (en) * | 2005-04-27 | 2006-11-02 | The Trustees Of The University Of Pennsylvania | Nanostructure enhanced luminescence |
US7919019B2 (en) * | 2005-04-27 | 2011-04-05 | The Trustees Of The University Of Pennsylvania | Nanostructure enhanced luminescent devices |
US20090246888A1 (en) * | 2005-04-27 | 2009-10-01 | The Trustees Of The University Of Pennsylvania | Nanoassays |
US7439079B2 (en) * | 2005-04-29 | 2008-10-21 | Kimberly-Clark Worldwide, Inc. | Assay devices having detection capabilities within the hook effect region |
US7858384B2 (en) * | 2005-04-29 | 2010-12-28 | Kimberly-Clark Worldwide, Inc. | Flow control technique for assay devices |
US7803319B2 (en) * | 2005-04-29 | 2010-09-28 | Kimberly-Clark Worldwide, Inc. | Metering technique for lateral flow assay devices |
US20060257883A1 (en) * | 2005-05-10 | 2006-11-16 | Bjoraker David G | Detection and measurement of hematological parameters characterizing cellular blood components |
US20100227382A1 (en) * | 2005-05-25 | 2010-09-09 | President And Fellows Of Harvard College | Nanoscale sensors |
WO2006132659A2 (en) * | 2005-06-06 | 2006-12-14 | President And Fellows Of Harvard College | Nanowire heterostructures |
US8033501B2 (en) * | 2005-06-10 | 2011-10-11 | The Boeing Company | Method and apparatus for attaching electrically powered seat track cover to through hole seat track design |
US20070026388A1 (en) * | 2005-07-28 | 2007-02-01 | Doorn Stephen K | Analyte detection using carbon nanotubes |
US7504235B2 (en) | 2005-08-31 | 2009-03-17 | Kimberly-Clark Worldwide, Inc. | Enzyme detection technique |
US7829347B2 (en) * | 2005-08-31 | 2010-11-09 | Kimberly-Clark Worldwide, Inc. | Diagnostic test kits with improved detection accuracy |
EP1945736A4 (en) * | 2005-10-27 | 2010-08-25 | Univ Clemson | Fluorescent carbon nanoparticles |
US8007267B2 (en) * | 2005-11-02 | 2011-08-30 | Affymetrix, Inc. | System and method for making lab card by embossing |
US8075852B2 (en) * | 2005-11-02 | 2011-12-13 | Affymetrix, Inc. | System and method for bubble removal |
US20080038714A1 (en) * | 2005-11-02 | 2008-02-14 | Affymetrix, Inc. | Instrument to Pneumatically Control Lab Cards and Method Thereof |
US20070099288A1 (en) * | 2005-11-02 | 2007-05-03 | Affymetrix, Inc. | Microfluidic Methods, Devices, and Systems for Fluid Handling |
US20080311585A1 (en) * | 2005-11-02 | 2008-12-18 | Affymetrix, Inc. | System and method for multiplex liquid handling |
US7279136B2 (en) * | 2005-12-13 | 2007-10-09 | Takeuchi James M | Metering technique for lateral flow assay devices |
US7618810B2 (en) | 2005-12-14 | 2009-11-17 | Kimberly-Clark Worldwide, Inc. | Metering strip and method for lateral flow assay devices |
US7645583B2 (en) | 2005-12-14 | 2010-01-12 | Kimberly-Clark Worldwide, Inc. | Identification of compounds for inhibiting complexation of C-reactive protein with fibronectin |
US7745158B2 (en) * | 2005-12-14 | 2010-06-29 | Kimberly-Clark Worldwide, Inc. | Detection of secreted aspartyl proteases from Candida species |
US8264137B2 (en) * | 2006-01-03 | 2012-09-11 | Samsung Electronics Co., Ltd. | Curing binder material for carbon nanotube electron emission cathodes |
US8008067B2 (en) | 2006-02-13 | 2011-08-30 | University Of Maryland, Baltimore County | Microwave trigger metal-enhanced chemiluminescence (MT MEC) and spatial and temporal control of same |
WO2007095527A2 (en) * | 2006-02-13 | 2007-08-23 | University Of Maryland Biotechnology Institute | Metal-enhanced chemiluminescence (mec) |
US8758989B2 (en) * | 2006-04-06 | 2014-06-24 | Kimberly-Clark Worldwide, Inc. | Enzymatic detection techniques |
DE602007012248D1 (en) | 2006-06-12 | 2011-03-10 | Harvard College | NANOSENSORS AND CORRESPONDING TECHNOLOGIES |
US7914460B2 (en) * | 2006-08-15 | 2011-03-29 | University Of Florida Research Foundation, Inc. | Condensate glucose analyzer |
US8058640B2 (en) | 2006-09-11 | 2011-11-15 | President And Fellows Of Harvard College | Branched nanoscale wires |
JP5009993B2 (en) | 2006-11-09 | 2012-08-29 | ナノシス・インク. | Nanowire arrangement method and deposition method |
US8575663B2 (en) * | 2006-11-22 | 2013-11-05 | President And Fellows Of Harvard College | High-sensitivity nanoscale wire sensors |
CN101558305A (en) | 2006-12-12 | 2009-10-14 | 皇家飞利浦电子股份有限公司 | Microelectronic sensor device for detecting label particles |
US7897360B2 (en) | 2006-12-15 | 2011-03-01 | Kimberly-Clark Worldwide, Inc. | Enzyme detection techniques |
US7868333B2 (en) * | 2006-12-21 | 2011-01-11 | E.I. Du Pont De Nemours And Company | Process for demetallization of carbon nanotubes |
US8084167B2 (en) * | 2007-01-24 | 2011-12-27 | Samsung Sdi Co., Ltd. | Nanocomposite for fuel cell, method of preparing the nanocomposite, and fuel cell including the nanocomposite |
US8197650B2 (en) * | 2007-06-07 | 2012-06-12 | Sensor Innovations, Inc. | Silicon electrochemical sensors |
EP2206136B1 (en) * | 2007-10-02 | 2013-03-27 | Hans-Henning Reis | X-ray rotating anode plate, and method for the production thereof |
FI20075767A0 (en) * | 2007-10-30 | 2007-10-30 | Canatu Oy | Surface coating and electrical devices comprising this |
US8535617B2 (en) * | 2007-11-30 | 2013-09-17 | Kimberly-Clark Worldwide, Inc. | Blood cell barrier for a lateral flow device |
WO2009073854A1 (en) | 2007-12-06 | 2009-06-11 | Nanosys, Inc. | Resorbable nanoenhanced hemostatic structures and bandage materials |
US8319002B2 (en) * | 2007-12-06 | 2012-11-27 | Nanosys, Inc. | Nanostructure-enhanced platelet binding and hemostatic structures |
US20090181361A1 (en) * | 2008-01-14 | 2009-07-16 | Weidong Xu | Rapid test for detecting infection |
US20100105024A1 (en) * | 2008-01-14 | 2010-04-29 | Transgenex Nanobiotech, Inc. | Rapid test including genetic sequence probe |
SI2271938T1 (en) | 2008-04-11 | 2014-07-31 | Board Of Regents Of The University Of Texas System | Method and apparatus for nanoparticle electrogenerated chemiluminescence amplification |
JP5583116B2 (en) | 2008-05-08 | 2014-09-03 | ボード・オブ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・テキサス・システム | Luminescent nanostructured materials for use in electrogenic chemiluminescence |
WO2010099446A1 (en) * | 2009-02-26 | 2010-09-02 | Massachusetts Institute Of Technology | Systems and methods using photoluminescent nanostructure based hydrogels |
US20100261292A1 (en) | 2009-04-10 | 2010-10-14 | Meso Scale Technologies, Llc | Methods for Conducting Assays |
US20120135158A1 (en) | 2009-05-26 | 2012-05-31 | Sharp Kabushiki Kaisha | Methods and systems for electric field deposition of nanowires and other devices |
CN106018857B (en) | 2009-07-27 | 2019-06-18 | 梅索磅秤技术有限公司 | Assay device, consumptive material and method |
US8993346B2 (en) * | 2009-08-07 | 2015-03-31 | Nanomix, Inc. | Magnetic carbon nanotube based biodetection |
WO2011038228A1 (en) | 2009-09-24 | 2011-03-31 | President And Fellows Of Harvard College | Bent nanowires and related probing of species |
US9216145B2 (en) | 2009-10-27 | 2015-12-22 | The Procter & Gamble Company | Semi-permanent cosmetic concealer |
US10034829B2 (en) | 2010-10-27 | 2018-07-31 | Noxell Corporation | Semi-permanent mascara compositions |
US9237992B2 (en) | 2009-10-27 | 2016-01-19 | The Procter & Gamble Company | Two-step mascara product |
US9004791B2 (en) | 2010-04-30 | 2015-04-14 | The Procter & Gamble Company | Package for multiple personal care compositions |
WO2011158068A1 (en) * | 2010-06-18 | 2011-12-22 | Centre National De La Recherche Scientifique (Cnrs) | Non covalent molecular structure, device comprising the same and its use for detection of lectin |
WO2012051519A2 (en) | 2010-10-14 | 2012-04-19 | The Johns Hopkins University | Biomarkers of brain injury |
JP5943927B2 (en) | 2010-10-14 | 2016-07-05 | メソ スケール テクノロジーズ エルエルシー | Reagent storage in assay devices |
CN101995402B (en) * | 2010-10-15 | 2012-08-29 | 济南大学 | Preparation and application of electrochemiluminescence sensor for detecting trace pesticide residue |
ES2581553T3 (en) | 2010-10-25 | 2016-09-06 | F. Hoffmann-La Roche Ag | Use of signal enhancing compounds in electrochemiluminescent detection |
CN102453067B (en) * | 2010-10-29 | 2015-08-05 | 中国科学院大连化学物理研究所 | A kind of NAD +the preparation method of analogue and application thereof |
WO2012083258A2 (en) | 2010-12-16 | 2012-06-21 | Sensor Innovations, Inc. | Electrochemical sensors |
WO2012094459A2 (en) | 2011-01-06 | 2012-07-12 | Glezer Eli N | Assay cartridges and methods of using the same |
US9879310B2 (en) * | 2011-01-31 | 2018-01-30 | The Regents Of The University Of California | Nano/microscale vehicles for capture and isolation of target biomolecules and living organisms |
JP2014518624A (en) | 2011-05-12 | 2014-08-07 | ザ・ジョンズ・ホプキンス・ユニバーシティー | Assay reagent for neurogranin diagnostic kit |
US9173824B2 (en) | 2011-05-17 | 2015-11-03 | The Procter & Gamble Company | Mascara and applicator |
TW201315679A (en) * | 2011-10-07 | 2013-04-16 | Nat Univ Tsing Hua | Production method for carbon nanotube sponges |
JP6300727B2 (en) | 2011-11-11 | 2018-03-28 | イーライ・エヌ・グレザー | Co-binder assisted assay |
US20130146439A1 (en) * | 2011-12-08 | 2013-06-13 | Vsevolod Rostovtsev | Photo-induced reduction-oxidation chemistry of carbon nanotubes |
JP6012767B2 (en) | 2012-02-07 | 2016-10-25 | ヴィブラント ホールディングス リミテッド ライアビリティ カンパニー | Substrates, peptide arrays, and methods |
JP2015519954A (en) | 2012-05-15 | 2015-07-16 | ザ プロクター アンド ギャンブルカンパニー | A method for quantitatively determining eyelash aggregation |
US10006909B2 (en) | 2012-09-28 | 2018-06-26 | Vibrant Holdings, Llc | Methods, systems, and arrays for biomolecular analysis |
US10286376B2 (en) | 2012-11-14 | 2019-05-14 | Vibrant Holdings, Llc | Substrates, systems, and methods for array synthesis and biomolecular analysis |
CA3071710C (en) | 2013-01-04 | 2021-03-16 | Meso Scale Technologies, Llc. | Assay apparatuses, methods and reagents |
CA2901029C (en) * | 2013-02-15 | 2020-06-16 | John J. Rajasekaran | Methods and compositions for amplified electrochemiluminescence detection |
EP2972353B1 (en) | 2013-03-11 | 2023-02-22 | Meso Scale Technologies, LLC | Improved methods for conducting multiplexed assays |
US10114015B2 (en) | 2013-03-13 | 2018-10-30 | Meso Scale Technologies, Llc. | Assay methods |
CA2904181A1 (en) | 2013-03-13 | 2014-10-09 | Anahit Aghvanyan | Sandwich immunoassay comprising anchoring reagent |
CN105209532B (en) | 2013-03-15 | 2017-11-28 | 路博润先进材料公司 | CPVC compositions without heavy metal |
US10534003B2 (en) | 2013-07-17 | 2020-01-14 | The Johns Hopkins University | Multi-protein biomarker assay for brain injury detection and outcome |
CA2947747C (en) | 2014-05-09 | 2024-03-05 | Meso Scale Technologies, Llc. | Graphene-modified electrodes |
KR20230022268A (en) | 2014-05-15 | 2023-02-14 | 메소 스케일 테크놀러지즈, 엘엘시 | Improved assay methods |
WO2016044697A1 (en) | 2014-09-19 | 2016-03-24 | The Johns Hopkins University | Biomarkers of cognitive dysfunction |
WO2016134365A1 (en) | 2015-02-20 | 2016-08-25 | The Johns Hopkins University | Biomarkers of myocardial injury |
US10294451B2 (en) | 2015-04-22 | 2019-05-21 | University Of Maryland, Baltimore County | Flow and static lysing systems and methods for ultra-rapid isolation and fragmentation of biological materials by microwave irradiation |
WO2017015531A1 (en) | 2015-07-22 | 2017-01-26 | University Of Maryland, Baltimore County | Hydrophilic coatings of plasmonic metals to enable low volume metal-enhanced fluorescence |
WO2017153574A1 (en) | 2016-03-11 | 2017-09-14 | Roche Diagnostics Gmbh | Branched-chain amines in electrochemiluminescence detection |
US10538808B2 (en) | 2017-05-26 | 2020-01-21 | Vibrant Holdings, Llc | Photoactive compounds and methods for biomolecule detection and sequencing |
EP4310184A3 (en) | 2018-02-23 | 2024-05-01 | Meso Scale Technologies, LLC. | Methods of screening antigen-binding molecules by normalizing for the concentration of antigen-binding molecule |
US20190369119A1 (en) | 2018-06-04 | 2019-12-05 | Avon Products, Inc. | Protein Biomarkers for Identifying and Treating Aging Skin and Skin Conditions |
KR20210146884A (en) | 2019-01-03 | 2021-12-06 | 메소 스케일 테크놀러지즈, 엘엘시 | Compositions and methods for performing assay measurements |
EP3931201A1 (en) | 2019-03-01 | 2022-01-05 | Meso Scale Technologies, LLC | Electrochemiluminescent labeled probes for use in immunoassay methods, methods using such and kits comprising same |
CN113939599A (en) | 2019-06-07 | 2022-01-14 | 豪夫迈·罗氏有限公司 | Hybrid all-LNA oligonucleotides |
CN110440863B (en) * | 2019-08-28 | 2020-10-16 | 安徽省中原仪表有限公司 | Roots flowmeter |
WO2021236584A1 (en) | 2020-05-19 | 2021-11-25 | Meso Scale Technologies, Llc. | Methods, compositions, and kits for nucleic acid detection |
US20220018785A1 (en) | 2020-07-01 | 2022-01-20 | Meso Scale Technologies, Llc. | Compositions and methods for assay measurements |
US11524283B2 (en) | 2020-12-21 | 2022-12-13 | Merichem Company | Catalytic carbon fiber preparation methods |
US11517889B2 (en) | 2020-12-21 | 2022-12-06 | Merichem Company | Catalytic carbon fiber contactor |
WO2022140273A1 (en) * | 2020-12-21 | 2022-06-30 | Merichem Company | Catalytic carbon fiber preparation methods |
US11826736B2 (en) | 2021-11-29 | 2023-11-28 | Merichem Company | Catalytic carbon fiber preparation methods |
CN116635083A (en) | 2020-12-22 | 2023-08-22 | 豪夫迈·罗氏有限公司 | Method for detecting target analytes in a sample |
WO2023129884A1 (en) | 2021-12-30 | 2023-07-06 | Meso Scale Technologies, Llc. | Methods for electrochemiluminescence detection |
WO2023156510A1 (en) | 2022-02-18 | 2023-08-24 | F. Hoffmann-La Roche Ag | Method for detecting an analyte of interest in a sample |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4663230A (en) * | 1984-12-06 | 1987-05-05 | Hyperion Catalysis International, Inc. | Carbon fibrils, method for producing same and compositions containing same |
US5310669A (en) * | 1992-06-22 | 1994-05-10 | The Trustees Of Dartmouth College | Fullerene coated surfaces and uses thereof |
US5547748A (en) * | 1994-01-14 | 1996-08-20 | Sri International | Carbon nanoencapsulates |
US5554751A (en) * | 1993-11-12 | 1996-09-10 | Hoechst Aktiengesellschaft | Aminoureidofullerene and aminothioureidofullerene derivatives and process for the preparation thereof |
US5582955A (en) * | 1994-06-23 | 1996-12-10 | State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon | Chemical functionalization of surfaces |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8417301D0 (en) * | 1984-07-06 | 1984-08-08 | Serono Diagnostics Ltd | Assay |
FI842992A0 (en) * | 1984-07-26 | 1984-07-26 | Labsystems Oy | IMMUNOLOGISKT DEFINITIONSFOERFARANDE. |
US5171560A (en) * | 1984-12-06 | 1992-12-15 | Hyperion Catalysis International | Carbon fibrils, method for producing same, and encapsulated catalyst |
US4951878A (en) * | 1987-11-16 | 1990-08-28 | Casey Gary L | Pico fuel injector valve |
US5705402A (en) * | 1988-11-03 | 1998-01-06 | Igen International, Inc. | Method and apparatus for magnetic microparticulate based luminescence assay including plurality of magnets |
GB9203037D0 (en) * | 1992-02-11 | 1992-03-25 | Salutar Inc | Contrast agents |
US20040202603A1 (en) * | 1994-12-08 | 2004-10-14 | Hyperion Catalysis International, Inc. | Functionalized nanotubes |
US6203814B1 (en) * | 1994-12-08 | 2001-03-20 | Hyperion Catalysis International, Inc. | Method of making functionalized nanotubes |
US5866434A (en) * | 1994-12-08 | 1999-02-02 | Meso Scale Technology | Graphitic nanotubes in luminescence assays |
JP3784072B2 (en) * | 1995-06-07 | 2006-06-07 | イゲン,インコーポレイテッド | Electrochemiluminescent enzyme immunoassay |
US5922692A (en) * | 1998-03-11 | 1999-07-13 | Marino; Richard P. | Concentration of glycosaminoglycans and precursors thereto in food products |
-
1996
- 1996-03-06 US US08/611,347 patent/US5866434A/en not_active Expired - Lifetime
-
1997
- 1997-03-05 AT AT97908967T patent/ATE363660T1/en active
- 1997-03-05 KR KR10-1998-0706856A patent/KR100463002B1/en not_active IP Right Cessation
- 1997-03-05 AU AU20737/97A patent/AU724509B2/en not_active Expired
- 1997-03-05 CA CA2248893A patent/CA2248893C/en not_active Expired - Lifetime
- 1997-03-05 DE DE69737765T patent/DE69737765T2/en not_active Expired - Lifetime
- 1997-03-05 ZA ZA9701915A patent/ZA971915B/en unknown
- 1997-03-05 CN CNB971943346A patent/CN1174248C/en not_active Expired - Lifetime
- 1997-03-05 IL IL12598597A patent/IL125985A/en not_active IP Right Cessation
- 1997-03-05 JP JP53198997A patent/JP3791930B2/en not_active Expired - Lifetime
- 1997-03-05 WO PCT/US1997/003653 patent/WO1997033176A1/en active IP Right Grant
- 1997-03-05 RU RU98116668/28A patent/RU2189043C2/en active
- 1997-03-05 EP EP97908967A patent/EP0885393B1/en not_active Expired - Lifetime
-
1999
- 1999-02-02 US US09/243,215 patent/US6362011B1/en not_active Expired - Lifetime
-
2001
- 2001-12-05 US US10/007,526 patent/US7052861B2/en not_active Expired - Fee Related
-
2006
- 2006-03-20 US US11/385,277 patent/US9505619B2/en not_active Expired - Lifetime
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4663230A (en) * | 1984-12-06 | 1987-05-05 | Hyperion Catalysis International, Inc. | Carbon fibrils, method for producing same and compositions containing same |
US5310669A (en) * | 1992-06-22 | 1994-05-10 | The Trustees Of Dartmouth College | Fullerene coated surfaces and uses thereof |
US5554751A (en) * | 1993-11-12 | 1996-09-10 | Hoechst Aktiengesellschaft | Aminoureidofullerene and aminothioureidofullerene derivatives and process for the preparation thereof |
US5547748A (en) * | 1994-01-14 | 1996-08-20 | Sri International | Carbon nanoencapsulates |
US5582955A (en) * | 1994-06-23 | 1996-12-10 | State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon | Chemical functionalization of surfaces |
Cited By (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0944820A4 (en) * | 1996-09-17 | 2000-04-26 | Meso Scale Technologies Llc | Multi-array, multi-specific electrochemiluminescent testing |
EP0944820A1 (en) * | 1996-09-17 | 1999-09-29 | Meso Scale Technologies, LLC. | Multi-array, multi-specific electrochemiluminescent testing |
EP1018015A4 (en) * | 1997-09-18 | 2005-10-19 | Meso Scale Technologies Llc | Assay sonication apparatus and methodology |
EP1018015A1 (en) * | 1997-09-18 | 2000-07-12 | Meso Scale Technologies LLC | Assay sonication apparatus and methodology |
US7008796B2 (en) | 1997-09-18 | 2006-03-07 | Mesoscale Technologies, Llc. | Assay sonication apparatus and methodology |
US9157113B2 (en) | 1997-10-06 | 2015-10-13 | Trustees Of Tufts College, Tufts University | Self-encoding sensor with microspheres |
US8691591B2 (en) | 1997-10-06 | 2014-04-08 | Trustees Of Tufts College | Self-encoding sensor with microspheres |
US8426217B2 (en) | 1997-10-06 | 2013-04-23 | Trustees Of Tufts College | Self-encoding sensor with microspheres |
JP2010249826A (en) * | 1997-10-06 | 2010-11-04 | Trustees Of Tufts College | Method of amplifying signal generated from enzyme reaction |
US6312896B1 (en) | 1998-09-17 | 2001-11-06 | Igen Inaternational, Inc. | Assays for measuring nucleic acid binding proteins and enzyme activities |
US7439017B2 (en) | 1998-09-17 | 2008-10-21 | Bioveris Corporation | Assays for measuring nucleic acid binding proteins and enzyme activities |
US6673542B2 (en) | 1998-09-17 | 2004-01-06 | Igen International Inc. | Assays for measuring nucleic acid damaging activities |
US6214552B1 (en) | 1998-09-17 | 2001-04-10 | Igen International, Inc. | Assays for measuring nucleic acid damaging activities |
CN1111573C (en) * | 1999-05-12 | 2003-06-18 | 中国科学院感光化学研究所 | Pneumatic pressure-sensitive lacquer and its preparing process |
DE10035365B4 (en) * | 2000-07-20 | 2005-02-10 | Infineon Technologies Ag | Method of inferring the existence of light from a dye-bound nanotube |
US6777960B2 (en) | 2000-07-20 | 2004-08-17 | Infineon Technologies Ag | Method of inferring the existence of light by means of a measurement of the electrical characteristics of a nanotube bound with a dye, and detection arrangement |
DE10035365A1 (en) * | 2000-07-20 | 2002-02-07 | Infineon Technologies Ag | Production of a photosensitive nanotube used in the production of nano switching circuits, comprises deriving the tube, and coupling a dye excited by light on the tube via the chemically reactive groups |
EP1552011A2 (en) * | 2002-07-23 | 2005-07-13 | THE TEXAS A & M UNIVERSITY SYSTEMS | Photonic signal reporting of electrochemical events |
EP1552011A4 (en) * | 2002-07-23 | 2006-11-08 | Texas A & M Univ Sys | Photonic signal reporting of electrochemical events |
US9986942B2 (en) | 2004-07-13 | 2018-06-05 | Dexcom, Inc. | Analyte sensor |
US10993641B2 (en) | 2004-07-13 | 2021-05-04 | Dexcom, Inc. | Analyte sensor |
US11883164B2 (en) | 2004-07-13 | 2024-01-30 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10524703B2 (en) | 2004-07-13 | 2020-01-07 | Dexcom, Inc. | Transcutaneous analyte sensor |
US11064917B2 (en) | 2004-07-13 | 2021-07-20 | Dexcom, Inc. | Analyte sensor |
US11045120B2 (en) | 2004-07-13 | 2021-06-29 | Dexcom, Inc. | Analyte sensor |
US11026605B1 (en) | 2004-07-13 | 2021-06-08 | Dexcom, Inc. | Analyte sensor |
US10993642B2 (en) | 2004-07-13 | 2021-05-04 | Dexcom, Inc. | Analyte sensor |
US10709362B2 (en) | 2004-07-13 | 2020-07-14 | Dexcom, Inc. | Analyte sensor |
US10709363B2 (en) | 2004-07-13 | 2020-07-14 | Dexcom, Inc. | Analyte sensor |
US9414777B2 (en) | 2004-07-13 | 2016-08-16 | Dexcom, Inc. | Transcutaneous analyte sensor |
US10918315B2 (en) | 2004-07-13 | 2021-02-16 | Dexcom, Inc. | Analyte sensor |
US10722152B2 (en) | 2004-07-13 | 2020-07-28 | Dexcom, Inc. | Analyte sensor |
US10980452B2 (en) | 2004-07-13 | 2021-04-20 | Dexcom, Inc. | Analyte sensor |
US10799159B2 (en) | 2004-07-13 | 2020-10-13 | Dexcom, Inc. | Analyte sensor |
US10799158B2 (en) | 2004-07-13 | 2020-10-13 | Dexcom, Inc. | Analyte sensor |
US10813576B2 (en) | 2004-07-13 | 2020-10-27 | Dexcom, Inc. | Analyte sensor |
US10932700B2 (en) | 2004-07-13 | 2021-03-02 | Dexcom, Inc. | Analyte sensor |
US10827956B2 (en) | 2004-07-13 | 2020-11-10 | Dexcom, Inc. | Analyte sensor |
US10918313B2 (en) | 2004-07-13 | 2021-02-16 | Dexcom, Inc. | Analyte sensor |
US10918314B2 (en) | 2004-07-13 | 2021-02-16 | Dexcom, Inc. | Analyte sensor |
US10709364B2 (en) | 2005-03-10 | 2020-07-14 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US11000213B2 (en) | 2005-03-10 | 2021-05-11 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10918317B2 (en) | 2005-03-10 | 2021-02-16 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10918318B2 (en) | 2005-03-10 | 2021-02-16 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10856787B2 (en) | 2005-03-10 | 2020-12-08 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10918316B2 (en) | 2005-03-10 | 2021-02-16 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10925524B2 (en) | 2005-03-10 | 2021-02-23 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10610136B2 (en) | 2005-03-10 | 2020-04-07 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10743801B2 (en) | 2005-03-10 | 2020-08-18 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10716498B2 (en) | 2005-03-10 | 2020-07-21 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10617336B2 (en) | 2005-03-10 | 2020-04-14 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10898114B2 (en) | 2005-03-10 | 2021-01-26 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10610135B2 (en) | 2005-03-10 | 2020-04-07 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US11051726B2 (en) | 2005-03-10 | 2021-07-06 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10610137B2 (en) | 2005-03-10 | 2020-04-07 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10813577B2 (en) | 2005-06-21 | 2020-10-27 | Dexcom, Inc. | Analyte sensor |
US11391733B2 (en) | 2015-08-20 | 2022-07-19 | Roche Diagnostics Operations, Inc. | Particle-based immunoassay using a pegylated analyte-specific binding agent |
US11971407B2 (en) | 2016-03-07 | 2024-04-30 | Roche Diagnostics Operations, Inc. | Detection of anti-p53 antibodies |
US11099180B2 (en) | 2017-02-02 | 2021-08-24 | Roche Diagnostics Operations, Inc. | Immunoassay using at least two pegylated analyte-specific binding agents |
US11041853B2 (en) | 2017-06-14 | 2021-06-22 | Sensogenic Ltd | Sensing system and method for detection of CBM containing analytes using their binding to cellulosic substrates |
WO2018229775A1 (en) * | 2017-06-14 | 2018-12-20 | Sensogenic Ltd | Sensing system and method for detection of cbm containing analytes using their binding to cellulosic substrates |
Also Published As
Publication number | Publication date |
---|---|
US20020086335A1 (en) | 2002-07-04 |
US7052861B2 (en) | 2006-05-30 |
US20060160246A1 (en) | 2006-07-20 |
CA2248893C (en) | 2012-01-03 |
ATE363660T1 (en) | 2007-06-15 |
JP3791930B2 (en) | 2006-06-28 |
DE69737765D1 (en) | 2007-07-12 |
KR100463002B1 (en) | 2005-08-17 |
EP0885393B1 (en) | 2007-05-30 |
CN1217791A (en) | 1999-05-26 |
EP0885393A1 (en) | 1998-12-23 |
AU2073797A (en) | 1997-09-22 |
CN1174248C (en) | 2004-11-03 |
EP0885393A4 (en) | 2000-10-18 |
JP2001507787A (en) | 2001-06-12 |
US9505619B2 (en) | 2016-11-29 |
AU724509B2 (en) | 2000-09-21 |
RU2189043C2 (en) | 2002-09-10 |
IL125985A (en) | 2002-07-25 |
US6362011B1 (en) | 2002-03-26 |
KR19990087434A (en) | 1999-12-27 |
CA2248893A1 (en) | 1997-09-12 |
US5866434A (en) | 1999-02-02 |
DE69737765T2 (en) | 2008-02-21 |
IL125985A0 (en) | 1999-04-11 |
ZA971915B (en) | 1997-09-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU724509B2 (en) | Graphitic nanotubes in luminescence assays | |
KR100469868B1 (en) | Functionalized Nanotubes | |
Jia et al. | NiCo2O4 spinel embedded with carbon nanotubes derived from bimetallic NiCo metal-organic framework for the ultrasensitive detection of human immune deficiency virus-1 gene | |
JP4601086B2 (en) | Functionalized nanotubes | |
TW541416B (en) | Multi-array, multi-specific electrochemiluminescence testing | |
KR20070030282A (en) | Functionalized single walled carbon nanotubes | |
US20040202603A1 (en) | Functionalized nanotubes | |
Fu et al. | Fabrication strategies for metal-organic framework electrochemical biosensors and their applications | |
Khan et al. | Electrochemiluminescent immunosensor for prostate specific antigen based upon luminol functionalized platinum nanoparticles loaded on graphene | |
IE920381A1 (en) | Method and apparatus for magnetic microparticulate based luminescence assay including plurality of magnets | |
Jian et al. | Electrochemiluminescence based detection of microRNA by applying an amplification strategy and Hg (II)-triggered disassembly of a metal organic frameworks functionalized with ruthenium (II) tris (bipyridine) | |
Li et al. | An enzyme-free photoelectrochemical sensing of concanavalin A based on graphene-supported TiO2 mesocrystal | |
Cai et al. | Detection of CYFRA 21-1 in human serum by an electrochemical immunosensor based on UiO-66-NH2@ CMWCNTs and CS@ AuNPs | |
Li et al. | Highly Sensitive Electrochemical Aptasensor for Detection of Glypican-3 Using Hemin-Reduced Graphene Oxide-Platinum Nanoparticles Coupled with Conductive Reduced Graphene Oxide-Gold Nanoparticles | |
Wang et al. | RecJf exonuclease-assisted signal amplification for the sensitive detection of di (2-ethylhexyl) phthalate by a Pd@ Au NB labeled electrochemical aptasensor based on Au@ Ni-CoHNB/PEI-gC 3 N 4 | |
CN110031528A (en) | A kind of TiO based on ZnO thin film2The ovarian cancer cell electrogenerated chemiluminescence sensing platform of mesomorphic nanometer plate catalysis enhancing | |
Yang et al. | A disposable and magnetic nano-particles composite membrane modified amperometric immunosensor for determination of chloramphenicol |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 97194334.6 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG UZ VN YU AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1997908967 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2248893 Country of ref document: CA Ref document number: 2248893 Country of ref document: CA Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1019980706856 Country of ref document: KR |
|
ENP | Entry into the national phase |
Ref document number: 1997 531989 Country of ref document: JP Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 1997908967 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 1019980706856 Country of ref document: KR |
|
WWG | Wipo information: grant in national office |
Ref document number: 1019980706856 Country of ref document: KR |
|
WWG | Wipo information: grant in national office |
Ref document number: 1997908967 Country of ref document: EP |